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Chapter 1: Introduction 
 
1.1 Functional peptide for biotechnology development  
 
1.1.1  Bioactive peptides 
Animals, plants, and microorganism must overcome the biotic and abiotic stresses that 
reduce their productivity, survivability, and resistivity (Hale and Orcutt, 1987; Mittler, 
2002; Orcutt, 2000; Tuteja and Sopory, 2008; Yang et al., 2009). A major focus of current 
research is the identification of peptides with properties that are useful for 
biotechnological applications, especially in the diagnosis of genetic disorders such as 
cancer and immunological, cardiovascular, and aging-related diseases (Kuster et al., 
2002; Wadia and Dowdy, 2005; Welch et al., 2007; Yu et al., 2005). A broad range of 
bioactive peptides with varied functions and structures, ranging from channel blockers to 
enzyme inhibitors, neuroprotective agents and substrates are now commercially available 
(Pihlanto-Leppälä, 2000; Yanagisawa et al., 1988). Moreover, bioactive peptides are 
extensively used commercially (Korhonen and Pihlanto, 2006). Assorted small peptides 
and solutes enable animals, plants, and microorganism to tolerate abiotic stresses (Goyal 
and Mattoo, 2014; Meier et al., 2008; Wang et al., 2004; Xu et al., 2006a). Abiotic and 
biotic stresses are complex, and various molecular, cellular, and physiological processes 
are involved in the survival of organisms by overcoming these stresses (Knight and 
Knight, 2001; Mittler, 2006).  A large body of evidence shows that a combination of both 
abiotic and biotic stresses can have negative effects on plant performance by increasing 
stress sensitivity (Chaves and Oliveira, 2004; Mckersie et al., 1996; Verslues et al., 2006). 
Peptide expression can provide a diverse repertoire of functionally and structurally 
distinct innate immunomodulatory that directly act against a wide range of pathogens 
(Gordon et al., 2005; Lai and Gallo, 2009; Park and Hahm, 2005; Tomàs Pérez and Boix 
Borrás, 2015). AMPs are constitutively expressed in response to microbial infections in 
nearly all plant organs (Fjell et al., 2012).  
For therapeutic purposes, peptides are characterized, isolated and purified from milk, 
plants, meat, and egg proteins (Kitts and Weiler, 2003; Korhonen and Pihlanto, 2006). 
Bioactive peptides are divided into several classes such as milk peptides, ribosomal 
peptides, non-ribosomal peptides, peptones and peptide fragments (Caboche et al., 2007; 
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Finking and Marahiel, 2004; Kitts and Weiler, 2003; Korhonen and Pihlanto, 2006). Such 
peptides are 30-100 kDa in size, and known to be biologically active molecules involved 
in the reduction of blood pressure, inhibition of prolyl endopeptidase, and stimulation of 
the immune system. Moreover, TRH (Thyrotropin-releasing hormone), angiotensin, 
vasopressin, oxytocin, and bradykinin play roles as an antioxidant, antibacterial, and anti-
thrombotic agents (Korhonen and Pihlanto, 2006; Pimenta and De Lima, 2005; Weihofen 
and Martoglio, 2003). Many bioactive peptides are characterized, designed, isolated, and 
purified from a single species by using a fragment from the genome bank. 
Bioactive peptides have various properties, including antiparasitic, antiviral, 
antibacterial, and antifungal activities (Boman, 1991; Lemaitre et al., 1996; Marr et al., 
2006). Bioactive peptides are classified by comparative analysis to identify their unique 
structural isomerization. Bioactive peptide molecules do not have any unique skeletal 
differentiator; most are rich in glycine and cysteine residues and possess disulfide bridges 
between the cysteine residues to increase stability (Diedrich and Julian, 2010; Zhang and 
Tam, 1997). Most bioactive peptides are hydrophobic, contain charged amino acids, and 
are primarily cationic. Natural bioactive peptides vary in length from 12 to 55 amino acid 
residues. Structurally, they contain combinations of β-sheets and α-helices, with looped 
or extended structures of these domains for stability (Wang et al., 2008). Natriuretic 
peptides (NP) have a critical role in host defense responses (Pandey, 2005; Yeung et al., 
2011). Table 1.1 shows a list of bioactive peptides. Each bioactive peptide is introduced 
in next subsection. 
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Table 1.1 Bioactive peptide 
S.No Types Subsection 
1 Antimicrobial peptide  1.1.2 
2 Theraupetic peptide 1.1.3 
3 Dietary peptide 1.1.4 
4 Tag peptide 1.1.5 
5 Molecular recognition peptide 1.1.6 
6 Abiotic stress 1.1.7 
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1.1.2 Antimicrobial peptides (AMPs) 
Antimicrobial peptides are novel therapeutic agents and broad-spectrum class of 
antibiotics to kill gram-positive and gram-negative bacteria, fungi, capsulated viruses and 
even transformed or cancerous cells (Jenssen et al., 2006; Mader and Hoskin, 2006; Peters 
et al., 2010). According to the APD (Antimicrobial Peptide Database), antimicrobial 
peptides have been identified in diverse species and divided into subgroups based on their 
amino acid composition and structure. Antimicrobial peptides are a diverse group of 
molecules pasturing from lower to higher organisms. Many of these peptides are 
unstructured in free solution, and fold into their final configuration upon partitioning into 
biological membranes (Reddy et al., 2004; Wang, 2017). The modes of mechanism and 
function by which peptides kill microbes are motley and can be analyzed by fluorescent 
staining, microscopy, dual polarization interferometry. (Brown and Hancock, 2006; De 
Lucca and Walsh, 1999)(Table 1.2).  
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Table 1.2 Antimicrobial peptide 
 
Source Name 
Features 
Peptide sequence Peptide activity APD ID 
Bacteria Baceridin  
 
WAIVLL  
 
Cancer cells AP02372  
 
Bacteria Nisin A 
 
ITSISLCTPGCKTGA
LMGCNMKTATCHC
SIHVSK 
anti-Gram+, 
Spermicidal, 
Surface 
immobilized 
AMPs, Antibiofilm, 
wound healing, 
Cancer cells 
 
AP00205 
 
Fugi Copsin  
 
QNCPTRRGLCVTSG
LTACRNHCRSCHRG
DVGCVRCSNAQCT
GFLGTTCTCINPCPR
C  
antiviral, Cancer 
cells 
 
AP02440 
Fungi Antiviral 
protein Y3 
 
AACARFIDDFCDTL
TPNIYRPRDNGQRC
YAVNGHRCDFTVF
NTNNGGNPIRASTP
NCKTVLRTAANRCP
TGGRGKINPNAPFL
FAIDPNDGDCSTNF 
 
antiviral, Cancer 
cells 
 
AP00023 
 
Plants Snakin-Z 
 
CARLNCVPKGTSGN
TETCPCYASLHSCR
KYG 
anti-Gram+ & 
Gram-, antifungal, 
Antioxidant, 
Enzyme inhibitor 
 
AP02258 
 
Plants Hispidalin 
 
SDYLNNNPLFPRYD
IGNVELSTAYRSFA
NQKAPGRLNQNWA
LTADYTYR 
 
anti-Gram+ & 
Gram-, antifungal, 
Antioxidant, 
 
AP02407 
 
Animals Bactenecin 
 
RLCRIVVIRVCR 
 
anti-Gram+ & 
Gram-, wound 
healing 
 
AP00008 
 
APD database (http://aps.unmc.edu/AP) 
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1.1.3 Therapeutics peptide 
To date, more than 7500 naturally occurring peptides have been discovered to play a 
crucial role in human biology (Albericio and Kruger, 2012; Vlieghe et al., 2010). These 
peptides play important roles in human physiology, metabolism, anti-pathogenic, anti-
cancerous, growth factors, hormones, neurotransmitters, ion-channel, ligands, among 
other functions (Lien and Lowman, 2003; Sato et al., 2006). For intracellular responses 
peptides are a specific, selective and efficacious trigger for cell signaling. Some intrinsic 
properties of peptides, such as low costs and excellent safety profiles, make them 
attractive targets of molecular biology and the biopharmaceutical industry. (Kieber-
Emmons et al., 1997; Latham, 1999) (Table 1.3).  
 
Table 1.3 Therapeutics peptide   
Name 
Amino 
acids 
(No) 
Features 
Sequence Peptide activity Source 
Teriparatide  34 SVSEIQLMHNL
GKHLNSMERV
EWLRKKLQDV
HNF 
Osteoporosis Eli Lily & Co. 
Pramilintide 37 KCNTATCATQ
RLANFLVHSSN
NFGPILPPTNV
GSNTY - NH2 
(S - S Bond) 
acetate salt 
Diabetes Amylin 
Nesiritide 32 SPKMVQGSGC
FGRKMDRISSS
SGLGCKVLRR
H 
Heart attack Johnson & 
Johnson 
Degarelix 25 MEUCPCLKGZ
SHTAXYAYPH
GZSA-N 
Prostate cancer Ferring 
Enfuvirtide 25 PEASPLKKXB
YDKLFXEVSJ
AOSA-N 
HIV 
 
Roche/Termeris 
https://www.drugbank.ca/drugs (Smolenski et al., 2007) 
 
7 
 
1.1.4 Dietary peptide  
    Peptides are protein fragments composed of amino acids linked together through N-
linkages or disulfide bonds (Jukes et al., 1969). Most dietary peptides are long and 
inactive, but are activated following enzymatic cleavage that can be achieved via 
fermentation or other food processing techniques or via the action of proteases in the 
gastrointestinal tract (Meisel, 1997; Möller et al., 2008). The product of protein digestion 
are peptides, and the breakdown to smaller molecules helps with nutrient absorption, 
which requires the combined functions of the endocrine, nervous, cardiovascular, and 
immune systems (Morganstern et al., 2011). Many foods are rich in proteins and peptides, 
including soybeans, eggs, and milk (Juillard et al., 1998; Lawrence et al., 2000). Milk 
protein furnishes a broad spectrum of bioactive peptides that have been categorized in 
four major areas: (1) infant development; (2) immunological development and function; 
(3) gastrointestinal development, activity, and function; and (4) microbial activity 
(Anderson and Moore, 2004; Erdmann et al., 2008; Hamosh, 2001). The nutritional 
benefits of milk include its antibiotic and probiotic actions. Furthermore, milk-borne 
bioactive peptides such as caseins, whey proteins, and other minor constituents exhibit 
important physiological and biochemical functions that have crucial impacts on human 
metabolism and provide immunity to infants and adults against pathogens and illnesses 
through the action of immunoglobulins, antibacterial peptides, antimicrobial proteins, 
oligosaccharides, and lipids  (Clare et al., 2003; Hancock and Lehrer, 1998). Isoflavone-
deprived soy peptide has effects on cancer and tumor-suppression. Soybean and other 
beans are rich in proteins and peptides (Mishra et al., 2010; Park et al., 2009). Eggs are a 
good source of two kinds of protein, so eggs are one of the highest and richest sources of 
dietary peptides. For example, egg yolks contain water soluble peptides used in 
osteoporosis therapies (Browne et al., 1969; DeLange and Huang, 1971; Roberts et al., 
1990)(Table 1.4). All grains also contain peptides and help to provide defense 
mechanisms. 
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Table 1.4 Dietary peptide  
Name 
Amino 
acids 
(No) 
Features 
Sequence Peptide activity Source 
Lactoferricin  24 KCFQWQRNMR
KVRGPPVSCIK
RDS 
 
Antimicrobial and 
calcium/phosphate are 
stabilizing to enhance 
absorption. 
Milk 
Isoflavo
ne-
deprived 
- unidentified Cancer cells Soyabea 
Vitellogenin-
2 
20 EKYDIEPAFSNS
KTYVYNYE 
Antioxidant, ACE 
inhibitory activity 
Egg 
Gliado
rphin 
 
7 H-Tyr-Pro-Gln-
Pro-Gln-Pro-Phe-
OH 
Opioid agonist 
 
Wheat 
 
L-carnosine 
 
2 Beta-Ala-His Anti-inflammatory and 
antioxidant 
 
Meat 
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1.1.5 Tag peptide for biotechnology 
    The recombinant approach offers the most profitable and cost-effective means for 
large-scale peptide manufacturing (Baneyx, 1999; Wurm, 2004). Protein and peptide tags 
refer to those peptides with more than a dozen amino acids that are used for the 
enhancement and improvement of the quality and quantity of recombinant proteins (Cull 
and Schatz, 2000; Krauland et al., 2007; Mann and Wilm, 1994). A considerable number 
of biologically active peptides act as novel antibiotics, and peptide (epitope) tags are used 
universally in recombinant production, protein purification, and protein detection. For 
example, peptide tags, antigens, epitope tags, and fluorescent tag are used 
interchangeably, referring to the likes of FLAG, Myc epitope, and poly-histidine 
(Einhauer and Jungbauer, 2001; Esposito and Chatterjee, 2006; Lichty et al., 2005; 
Waugh, 2005)(Table 1.5). These peptide tags enhance the quality of recombinant protein 
and allow easy recognition of the end product. Peptide tags are prefixed to recombinant 
proteins to simplify their detection and purification (Bandeira et al., 2006).  They are also 
used to identify the potential binding partners of proteins to cells, tissues, and organs 
(Terpe, 2003; Waugh, 2005). In the post-genomic era, functional studies of genes and 
gene sequences rely in part on the characterization of the functional and structural 
properties of protein products. In recombinant protein expression and purification, the 
concurrent use of fusion tags with recombinant DNA cloning technology has become a 
conventional practice (Cull and Schatz, 2000; Krauland et al., 2007; Mann and Wilm, 
1994). Over the years, many affinity tags have been developed to facilitate the expression 
and purification of recombinant proteins from Escherichia coli (Baneyx, 1999; Hearn and 
Acosta, 2001; Rosano and Ceccarelli, 2014). The most popular methods of purification 
of recombinant proteins, are commercially available expression vectors and their 
downstream purification systems.  
All tags, regardless of size, impede upon the structure and functions of an expressed 
target protein and need to be removed during or after purification (Ikeda et al., 2010; 
Junttila et al., 2005). Thus, a specific proteolytic site on an expression vector cleavage 
site is often introduced between the tag and the recombinant protein (Terpe, 2003). 
Among the many site-specific proteases used for the cleavage of tags from target proteins, 
the most widely used is thrombin due to its high specificity and rarity of its target 
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sequence in natural proteins (Esposito and Chatterjee, 2006; Li, 2010; Terpe, 2003). 
Despite the widespread use of these tailor-made expression vectors and purification 
strategies, frustrations often occur when a target protein is expressed either at a low level 
or as insoluble inclusion bodies (Baneyx, 1999; Sørensen and Mortensen, 2005a, b). 
Although a His-Tag may allow unfolding with a denaturant, purification of insoluble 
proteins after complete refolding and full recovery of active biological functions may be 
less predictable with a recombinant protein. Furthermore, the yield and purity of a 
recombinant protein depend on the endogenous expression level in the host cell, and, 
therefore, a single affinity column may not be sufficient to recover all molecules 
(Backhaus et al., 2004; Ladner et al., 1990; Tsumoto et al., 2003). 
 
Table 1.5 Tag peptide 
Name 
Amino acids 
(No) 
Features 
Sequence Peptide activity Capture agent 
Flag 8 DYKDDDDK Epitope tag Antibody 
His 6 HHHHHH Purification tag Metal Organic 
complex 
T7 11 MASMTGGQQMG Epitope tag Antibody 
Myc 10 EQKLISEEDL Epitope tag Antibody 
HA 9 YPYDVPDYA Epitope tag Antibody 
https://www.sigmaaldrich.com 
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1.1.6 Peptide for molecular recognition materials 
 
Biomolecules such as proteins and peptides have been designed, constructed, and 
developed for use in a variety of applications (Lynch and Dawson, 2008; Xu et al., 
2006b). New nano-scale materials based on naturally occurring molecules can by 
synthesized from various inorganic materials using sustainable methods(Giljohann et al., 
2010; Lynch and Dawson, 2008). Rapidly used and identified peptides binding sequence 
occur in nature. Interestingly, physical biometric approaches characterize peptide-based 
surfaces by analyzing their shape, composition, structure, and size of the functional 
groups (inorganic materials) and peptides (Lynch and Dawson, 2008; Mikhalevich et al., 
2016). For functional active peptide-based surfaces, new biometric approaches and a 
better understanding of abiotic and biotic interfaces are required. The emergence of 
nanoparticle-based functionalization of peptides has advanced the application of these 
peptides in biosensing, plasmonics for storage of energy, medical devices, and 
therapeutics (Dev, 2010; Tice and Gilley, 1990; Yun et al., 2009). 
1.1.7 Peptide for abiotic stress 
In plant development and abiotic or biotic stress responses, small signalling peptides 
play an essential role in cell to cell messengers (Camilli and Bassler, 2006; Kondo et al., 
2006; Schlessinger, 2000). At the cellular level, chang in the chemical environment of the 
cells are perceived either directly or indirectly, and transduced through a complex 
signalling network, resulting in an appropriate response for stresses such as cold, heat, 
drought, salinity, and attack of the pathogen (Breen et al., 2017; Meier et al., 2008). 
AtCAPE1 cysteine-rich peptide confers salt sensitivity, while plant elicitor peptide (Pep) 
AtPep1, derived from the precursor peptide PROPEP1, acts as a damage-associated 
molecular pattern (DAMP) promoting the expression of pathogen defence genes (Chien 
et al., 2015). LEA peptide (MDAKDGTKEKAGE) confers salt, heat, and cold tolerance 
in E.coli BL 21 (DE3) (Chapter 4) (Pathak and Ikeno, 2017). 
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1.1.8 Peptide for recombinant protein expression  
   In the last two decades,  since the production of the first recombinant protein at the 
cellular level using genetic engineering, large-scale industrial production of recombinant 
products has been realized and more products are being introduced at a rapid rate (Galante 
and Formantici, 2003; Jarvis, 2009).  Since then, hundreds of commercially available 
biologically active proteins from different origins (from the nucleus to organs) have been 
produced by genetically modified organisms (Ma et al., 2003; Niemann et al., 2005; 
Tribe, 1976). Using biotechnological processes, major biopharmaceuticals and 
therapeutic recombinant proteins are obtained for commercial use. Production of such 
active biological recombinant proteins and biopharmaceutical therapeutic recombinant 
proteins has been achieved in microorganisms, organs, tissues, organisms, animal fluids, 
or genetically modified cells (Demain and Vaishnav, 2009; Kirschbaum, 1985; Kost et 
al., 2005; Morris et al., 2001; Thomas et al., 2003). Several different types of expression 
systems have been employed and new technological advancements are continuously 
being devised to improve the production of biopharmaceuticals using microorganisms, 
mammalian cell lines, insects, and plants (Jayapal et al., 2007; Tribe, 1976). This 
investment is possible due to the availability of well-characterized genomes, versatile 
plasmid vectors, different host strains, and cost-effectiveness compared with other 
expression systems. Different strategies have been developed for optimization of 
recombinant protein production in host cells. Even after careful selection of plasmid and 
host, whether or not a sufficient quantity of soluble or active forms of protein can be 
obtained cannot be predicted (Choi et al., 2006; Sørensen and Mortensen, 2005a; Westers 
et al., 2004; Wurm and Bernard, 1999; Wurm, 2004). Various situations that impede the 
cost-effective protein products can arise, and these scenarios are frequently encountered. 
Proteins have essential biological roles, both structurally and functionally (Tribe, 1976). 
In living organisms, active peptides serve various functions at both tissue and organ 
levels, acting as regulatory compounds, hormone-like substances, and promote different 
activities during gastrointestinal digestion or food processing (Fellows, 2009; Korhonen 
and Pihlanto, 2003; Meisel, 2004; Morimoto et al., 1990; Wrighton et al., 1996). As per 
society requirement and the benefits of the human being express peptides have become 
unique aspect for therapeutic applications (Johnson et al., 2011; Petros and DeSimone, 
2010; Potter et al., 2009; Seo et al., 2012). Peptidomics is an important tool for the 
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efficient production of bioactive peptides of various sizes and provides information on 
the choice of chemical and recombinant routes of production (Agyei et al., 2016; 
Udenigwe, 2014). Small bioactive peptides are of great interest due to their potential 
applications and cell-to-cell interactions in animals, plants, and microorganisms 
(Hubbell, 1999; Schuler et al., 2006; Zhou et al., 2009). 
For protein expression, construction of peptides to comply with an expression of 
transformant specifications, in concert with thorough out improve protein yields, or 
expression, expression conditions. Significantly, Ikeno et. al., 2013; have developed a 
LEA (late embryogenesis abundant) peptide co-expression system to boost protein 
expression in E. coli. Through the LEA peptide co-expression system, green fluorescence 
protein (GFP), chloramphenicol acetyltransferase (CAT), and β-glucuronidase (GUS) 
protein expression increased with increased incubation time (Ikeno and Haruyama, 2013). 
In the next section, the details of the LEA peptide co-expression system for increased 
protein expression in E. coli are introduced. 
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1.2 LEA peptide for efficient protein expression system 
 
For overexpression of transgenic proteins in E.coli, an efficient protein expression 
system which co-expresses the LEA peptide has been developed (Ikeno and Haruyama, 
2013). The design and characteristic properties of this peptide are based on the primary 
structure of a Group 3LEA protein from Polypedilum vanderpanki larvae that is a known 
hydrophilic protein, which suppresses aggregation and acts as a molecular shield against 
other protein molecules inside cells (Browne et al., 2002; Kikawada et al., 2006). 
 
1.2.1 LEA protein 
LEA (late embryogenesis abundant) proteins were first described 25 years ago as 
accumulating late in plant seed development. LEA proteins were first characterized and 
discovered in cotton seed (Gossypium hirsutum) and wheat plants (Dure, 1993; Dure et 
al., 1989; Ried and Walker-Simmons, 1993). The LEA proteins expressed during seed 
development at late embryogenesis account for 4% of all cellular proteins. Genes of LEA 
proteins have been identified in many plants, animals, and higher and lower 
microorganisms (Goyal et al., 2005a). Sequencing, amino acid abundance analysis, and 
expression pattern studies identified six different groups of LEA proteins; the 
corresponding proteins were initially referred to as dehydrins (D-7, D-11, D-19, D-29, D-
34, D73, D95 and D-113), according to their molecular weights (Close, 1996; Dure, 1993; 
Dure et al., 1989). Very rapidly, similar proteins were discovered in other species, and 
their classifications were based upon sequence similarities. Depending on the research, 
proteins were classified as: group 1 (proteins identical to D19), 2 (similar to D11), 3 
(similar to D7), 4 (similar to D113), 5 (similar to D29) and 6 (identical to D34). The major 
categories of LEA proteins are group 1, group 2 and group 3 (Figure 1.1) (Bray, 1993; 
Close, 1996; Dure, 1993; Dure et al., 1989; Wise and Tunnacliffe, 2004).  
Group 1 LEA proteins, of which wheat Em protein is a type, have been further 
subdivided into two super-families by Wise et al. 2007, and are only found in plants. They 
are unstructured in solution but contain a conserved 20-residue amino acid motif, most 
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often as one copy (Cuming, 1999; Gilles et al., 2007; Swire-Clark and Marcotte, 1999; 
Tunnacliffe and Wise, 2007).  
Group 2 LEA proteins, which Wise et al. (2007) suggest comprising three super families, 
are also known as ‘Dehydrins,’ and are mainly found in plants, including algae. Group 2 
proteins are characterized by up to three sequence motifs, known as the K-domain (lysine-
rich), the Y-domain (DEYGNP), and the S-segment (poly-serine stutter). Again, they are 
mostly unstructured, although they show some α-helical content (Close, 1996, 1997; 
Rorat, 2006; Tunnacliffe and Wise, 2007).  
Group 3 LEA proteins, comprising two super families, are characterized by an 11-mer 
repeated amino acid motif sequence whose consensus has been broadly defined as 
ΦΦE/QXΦKE/QKΦXE/D/Q (where Φ represents a hydrophobic residue). A genetic 
study in D. radiodurans supports a role for group 3 LEA proteins in desiccation tolerance, 
but, again, their precise function is unknown (Dure, 1993; Dure et al., 1989). 
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Figure 1.1 LEA protein consensus sequences 
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It is interesting to note that LEA protein genes are present not only in all  plants but also 
in animals, mosses, some mycelia such as truffle tubers, the bacteria 
(prokaryotes) Deinococcus radiodurans, Bacillus subtilis and Haemophilus 
influenza; and the nematodes Caenorhabditis elegans, Steinernema 
feltiae and Aphelenchus avenae (Rajesh and Manickam, 2006; Rebecchi et al., 2007; 
Tunnacliffe and Wise, 2007; Watanabe, 2006). The group 3 LEA protein from the 
anhydrobiotic nematode A. avenae is an example of a putative natively unfolded protein 
in salt solution, but seems to become more structured upon drying (Furuki et al., 2012; 
Furuki et al., 2011; Hatanaka et al., 2015; Shimizu et al., 2010). It appears that at least 
some LEA proteins are induced in vegetative tissues in response to water, cold or saline 
stress, making their seed specificity questionable. Adaptation to water shortage is mostly 
mediated by the stress phyto-hormone abscisic acid (ABA) and, classically, LEA 
synthesis is considered to be regulated by ABA. Indeed, several LEA genes have been 
used to elucidate ABA signaling pathways (de Torres‐Zabala et al., 2007; Shinozaki and 
Yamaguchi-Shinozaki, 2007; Valliyodan and Nguyen, 2006).  
The main physical characteristics of LEA proteins are their hydrophilicity and their 
intrinsic lack of structure (Chakrabortee et al., 2007; Kikawada et al., 2006; Tolleter et 
al., 2007). However, following desiccation or extreme temperature exposure some LEA 
proteins adopt specific three-dimensional structures. Recently, in vitro studies showed 
that some LEA proteins could protect enzyme activities or interact with sugar to prevent 
protein aggregation, as well as act as chaperones (Furuki et al., 2012; Furuki et al., 2011; 
Hatanaka et al., 2015; Shimizu et al., 2010). Some researchers have demonstrated that 
several LEA proteins can undergo phosphorylation, sequester ions or biotin, or are 
associated with vacuoles or lipid vesicles. However, this information on specific proteins 
cannot be extended to other LEA proteins, whose in vivo biological functions remain 
elusive (Hincha and Thalhammer, 2012; Hong-Bo et al., 2005; Tunnacliffe and Wise, 
2007; Wise and Tunnacliffe, 2004). Individual authors have described overexpression of 
plant LEA proteins in yeast and bacteria as conferring increased tolerance to osmotic or 
salt stresses (Li-Min and Jia-Ning, 2007; Miyasaka et al., 2000). Specific domains of two 
LEA proteins have recently been described as capable of inhibiting E. coli growth (Bies-
Etheve et al., 2008; Tunnacliffe and Wise, 2007).  
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1.2.2 Function of LEA protein 
Thought to be important in the metabolic dry state, LEA proteins represent one of the 
functional elements of biological structures, and maintain the viability of organisms. LEA 
proteins are expressed in some desiccation-tolerant micro-organisms, anhydrobiotic 
invertebrates, tissues, seeds and pollen of plants and also in some species of animals 
(Chakrabortee et al., 2007; Goyal et al., 2005b; Kikawada et al., 2006; Swire-Clark and 
Marcotte, 1999; Tolleter et al., 2007; Tunnacliffe and Wise, 2007). Their expression is 
linked to the acquisition of desiccation tolerance in orthodox seeds, pollen, and 
anhydrobiotic plants, but many LEA proteins are induced by cold or osmotic stress, by 
exogenous abscisic acid, or are even expressed constitutively, 
e.g., dhnX from Arabidopsis thaliana (Hundertmark and Hincha, 2008). Their precise 
functions are unknown, but they are assumed to protect cellular or molecular structures 
from the damaging effects of water loss; some putative mechanisms have been proposed, 
including hydration buffering, ion sequestration, direct protection of other proteins or 
membranes or renaturation of unfolded proteins. However, these suggested functions are 
supported by relatively little evidence (Bies-Etheve et al., 2008; Tunnacliffe et al., 2010). 
There seems to be some effect on stress tolerance. LEA proteins confer increased 
resistance to osmotic or freeze stresses when introduced in tomato, wheat, barley, and 
yeast (Babu et al., 2004). Barley LEA protein improves tolerance of water deficits in 
transgenic rice and wheat; furthermore, in vitro, an algal LEA protein diminished freeze 
damage in the enzyme LDH (lactate dehydrogenase)(Goyal et al., 2005a; Goyal et al., 
2005b; Veeranagamallaiah et al., 2011). 
LEA proteins are 10-30 kDa low molecular weight proteins, which are expressed in 
higher plants under environmental stresses, especially drought (dehydration) to protect 
cells, tissues or organs (Tunnacliffe and Wise, 2007). These findings, and the fact that the 
breeding of drought-tolerant varieties would be of great value in agriculture from the basis 
of the search for anti-drought inducible genes and their characterization (Goyal et al., 
2005b; Hong-Bo et al., 2005; Swire-Clark and Marcotte, 1999). As stated previously, 
LEA proteins are classified into six groups (families) according to their mRNA homology 
and amino acid sequence similarity (Bies-Etheve et al., 2008; Dure, 1993; Dure et al., 
1989; Shinozaki and Yamaguchi-Shinozaki, 2007).  LEA protein biological activities, 
mainly synthesis and expression, are regulated by many factors (e.g., developmental 
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stages, hormones, ion changes, and dehydration), signal transduction pathways, and LEA 
genes. LEA gene expression is not tissue-specific and is considered as one central 
regulatory mechanism, and is an essential feature of modern plant molecular biology. 
Although they are widely assumed to play crucial roles in abiotic, biotic, and cellular 
dehydration tolerance, their biochemical and physiological functions are mostly unknown 
(Bies-Etheve et al., 2008; Tunnacliffe et al., 2010; Veeranagamallaiah et al., 2011). 
Group 1 and three proteins are also found in bacteria and certain invertebrates (Honjoh 
et al., 1999; Veeranagamallaiah et al., 2011). Their precise molecular functions are 
unclear, however. Group 3 LEA proteins are primarily unstructured in solution, probably 
because their extreme hydrophilicity favors interaction with water over intra-chain 
binding, but they show increased folding when dried or associated with phospholipid 
bilayers (Furuki et al., 2012; Furuki et al., 2011; Hatanaka et al., 2015; Shimizu et al., 
2010). Many studies indicate a wide range of sequence similarities, intracellular 
localizations, and expression patterns. The high fraction of retained duplicate genes, and 
their inferred functional diversification suggest that they confer under varying stressful 
environmental conditions an evolutionary advantage to an organism. This comprehensive 
analysis will be an essential starting point for future efforts to elucidate the functional role 
of these enigmatic proteins. 
 
1.2.3 P. vanderplanki larvae: Group 3 LEA protein 
Group 3 late embryogenesis abundant (G3LEA) proteins, with characteristic 11-mer 
motifs, have amino acid sequences known to reduce aggregation of proteins originating 
from insects (P. vanderplanki), nematodes and plants (Babu et al., 2004; Furuki et al., 
2012; Furuki et al., 2011; Hatanaka et al., 2015; Shimizu et al., 2010).  The 11-mer motif 
has, in general, many polar residues, such as three Lys, two Glu, and one Asp, so that 
G3LEA proteins are highly hydrophilic (Dure et al., 1989). G3LEA proteins have unusual 
properties compared to many globular proteins since, while they are intrinsically 
disordered in solution, they can develop secondary structure, often predominantly α-
helical, upon desiccation, as shown for various G3LEA proteins originating from a 
nematode (Furuki et al., 2011; Goyal et al., 2005b).  G3LEA protein sequences can reduce 
protein aggregation by pH effects at high molar ratios and therefore have potential as 
stabilization reagents caused by desiccation (Furuki and Sakurai, 2012, 2014). That 
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demonstrates the high hydrophilic character of group 3 LEA proteins from P. 
vanderplanki induced by both desiccation and salt stress (Figure 1.2) (Furuki et al., 2012; 
Furuki et al., 2011; Hatanaka et al., 2015; Shimizu et al., 2010). 
Database encoding proteins (PvLEA1, PvLEA2, and PvLEA3) from desiccating larvae 
and isolated three cDNAs with highly bout to Group 3 LEA proteins notably (Figure 1.3, 
Figure 1.4, and Figure 1.5).  Both protein and mRNA levels of all three (PvLEA1, 
PvLEA2, and PvLEA3) examples increased under dehydration due to imposed by either 
hypersalinity or desiccation and one protein, PvLEA2, is likely to be post-translationally 
processed into smaller molecules(Hatanaka et al., 2015; Kikawada et al., 2006). 
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Figure 1.2 Role of PvLEA protein under the dehydration stress 
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Figure 1.3 PvLEA1 protein sequence: Length:742, Mass (Da):83,287, Last 
modified:May 2, 2006 - v1, Checksum:iE747CD256704501C 
 
  
10 20 30 40 50
MVLGSILRVD TCLCCFRIES GGIFVGAFGL FYAVIQIFAQ ICLMIYLMAV
60 70 80 90 100
ENFCPERFFA HDNRIDRQIR HDVANVTNMA LENIQNVTNT DLTCTQINKI
110 120 130 140 150
PVGLLLIIGI ILNLISIIAH YRLVKGIEES NVHKFPLTLN YYKFWIGIKL
160 170 180 190 200
ILLAIFGVWT FFNSKMIWIA IVTLLLLLFD VYIYTIIDTL RFKYENHPPV
210 220 230 240 250
NLLYTTLNSQ KGNYREEDEC NYCDETKSKF KEVKDAAGEK MENAKEKIIQ
260 270 280 290 300
VKEAAKDKIG HAVDVTTDKL GQAKDATAEK LVQAKDATAE KLGYAKDVTA
310 320 330 340 350
EKLGLAAEKT KETLVDAKDT IVEAKDTTKE KLGHAADVTA DKLGHAKDVT
360 370 380 390 400
ADKLGQAAEK TKETLVDAKD ATKDKLVQAK DVTADKLGHA KDVTKDKLAQ
410 420 430 440 450
AADKTKETLV ETKDKTADKL GQAADKTKEK LVEAKDVTAD KLGHAKDVTA
460 470 480 490 500
DKLGRAAEKT KETLVDAKDT TKDKLAYAKD VTADKLNYAA DKTKEKLVDA
510 520 530 540 550
KDTTKDKLGY AADKTKEKLA DAKDTTKDKF GDAKEATKDK YEDAKQKMAE
560 570 580 590 600
TKDKAKEKFF EAKDATADKL GNAKDATKDK LGYAADKTKE KYDEAKDATK
610 620 630 640 650
DKLGYAKDKL VETKDAAKDK TKEKYEEAKD KFGQARDVTK ERWDETKDAA
660 670 680 690 700
KNKYGDMRSN VQMENWNNTR DRYGNVIQRP DEPRDKITVA AVTTRETVTQ
710 720 730 740 750
IRKDNEPQTI INDNPQKARY FEQYSAVYVN PQDQQKMDKI IC        
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Figure 1.4 PvLEA2: protein sequence: Length:742, Mass (Da):83,287, Last 
modified:May 2, 2006 - v1, Checksum:iE747CD256704501C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 20 30 40 50
MKHDKGIIEE AKEKIIDVKD AAKEKVQNAA ETVKKALTGN EHEMDEAKQT
60 70 80 90 100
IKDKAYETKE AVKDKAHETK EAIKDKAYDA KETVKEKYEN AKEKVKDAGD
110 120 130 140 150
GIKDKYDATK EAARDTYEDA KKKVKGTDEE WKPMETKEEY LKDKYYKNNF
160 170 180 190 200
NPIAIFESIM QPESSQMASL ALNTLRRIPK                     
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Figure 1.5 PvLEA3: protein sequence: Length:742, Mass (Da):83,287, Last 
modified:May 2, 2006 - v1, Checksum:iE747CD256704501C 
 
 
 
 
 
 
 
 
 
  
10 20 30 40 50
MEKTLNEKTI LQPKTVFNID NFLGLFSLEA GGIFIGSVGL VWSIVQVFLH
60 70 80 90 100
SASLLSMKYV DNFCPQWPKI FHYLTRFPQQ AHQGIKNVTN MASEGYEVLK
110 120 130 140 150
NKIPEGYEVL KDKLPDGYEA LKDKIPETYE TLKNKIPEGY EALKDKIPDG
160 170 180 190 200
IKEAAQTAQE TFMDTSGRVQ EGIKEAAVKI KEGVRDASGR VQENLQDVTG
210 220 230 240 250
KVQDKFNDVS GSIKDNLPNV AGRVQDKFND VSGAIKDNLP DVAGRVKDNL
260 270 280 290 300
SEVTGKVQDK FNDVSGSIKD NLPNVAGKVQ EGYENIKNRA PETFHDAKNR
310 320 330 340 350
LGDSYDDIKR RVGEKYYDVK DQAQGTFYDV KNKAGEKLQD VANEETCSEI
360 370 380 390 400
SKYSFGALML FLIGANIVSI VAHYRLIKAV EESNASKLRL SLCYYKFFIG
410 420 430 440 450
FKLVFLAILG VSSLYSEEMF YPAISLLVLL LIDIYIFNVL DTLSFVFSNT
460 470 480 490 500
PHKTVLYTQQ IIRKKEIYDE IPHNEDLEIE DKSK                
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1.2.4 Design of LEA peptide 
The design of the LEA peptide was based on the P. vanderplanki larvae of three LEA 
proteins (PvLEA1, PvLEA2, and PvLEA3) (Ikeno and Haruyama, 2013). A sequence 
frequently found in these LEA proteins was identified, and the peptide was designed Ala-
Lys-Asp-Gly-Thr-Lys-Glu-Lys-Ala-Gly-Glu selected as the repeating unit of the LEA 
protein. (Figure 1.6). 
 
 
 
 
 
Figure 1.6 Amino acid sequence of LEA peptide 
 
 
1.2.5 LEA peptide co-expression system 
For efficient expression of the protein, conventional methods are used to enhance the 
quality and quantity of recombinant proteins, such as expression with a hydrophilic 
protein tag, use of multicopy plasmids, and enhancement of promoter activity. All types 
of expressed recombinant proteins and different types of conventional genetic methods 
using host cells are not sufficiently versatile. In traditional Tag expression systems, 
protein expression tags must be removed by protease digestion.   
Previously, Ikeno et al. (2013) developed an efficient protein expression system using 
co-expression of LEA peptides to enhance the expression of a recombinant protein (Ikeno 
and Haruyama, 2013). Co-expression of subunits is a valid technique for the study of 
protein heterologous complexes. The plasmid system allows generation and co-
expression of an unlimited number of high quality protein complexes in E. coli or other 
    AKDGTKEKAGE 
1,9       → hydrophobic 
5          → hydrophilic 
2,6,8    →     positive charge 
3,7,11  → negative charge 
4,10     → random 
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host cells by a robust and standardized co-expression system. In previous studies, LEA 
peptide sequences were designed to enhance the expression of target proteins through co-
expression. LEA peptides are hydrophilic and based on the 11-mer residues of group 3 
LEA proteins. The expression of GFP fluorescence with co-expression of each protein 
containing between one and six repeating 11aa LEA peptides is a very simple method to 
detect only the fluorescence without extracting it from cells (Figure 1.7). Fluorescence 
intensity of GFP decreased when co-expressed with the 2 to 6 repeating lengths of LEA 
peptides, and fell to almost zero when a 6- repeating length peptide was co-expressed. 
The co-expressed, non-repeated LEA peptide effectively increased GFP fluorescence 
intensity in the cell. When the 2-to-6 repeated peptides were co-expressed, the relative 
amounts of the GFP ratio decreased against the ratio without co-expression of the LEA 
peptide. (Figure 1.8a). One the other hand, the transcriptional levels of gfp mRNA in each 
sample were shown to be identical by the relative standard-curve method through Real-
time PCR (Figure 1.8b). These results indicate that LEA peptide does effectively function 
after translation, and inhibits the aggregation of GFP molecules in the cytoplasm, and 
thereby increases protein expression inside the cell. Various types of LEA peptide were 
designed based on the original LEA I peptide (Figure 1.9a) by exchanging functional 
amino acids with glycine residues. These changes produced peptide LEA-I and LEA-II, 
in which the charged amino acid and hydrophobic amino acid, respectively, enhanced co-
expression. In contrast, the expression of GFP was decreased with fewer functional 
residues containing LEA peptides (Figure 1.9b,c) (Ikeno and Haruyama, 2013).  
 
The present elevation of protein expression through the use of a LEA peptide is highly 
versatile. This method is simple, in that the protein is co-expressed with only a 13-amino 
acid peptide. Also, the separation process for protein purification is straightforward, 
because the co-expressed peptide is minimal. Therefore, these results could have a 
considerable impact, not only in applications involving bacterial protein expression but 
also in molecular biology. In the system, the expression of the target protein was 
remarkably increased by co-expression with a LEA peptide. In conclusion, this system is 
highly versatile but and why when increasing the length 2 to 6 repeat in LEA peptides 
decreases the target protein expression inside the cells if single LEA peptides (LEA I and 
LEA II) enhance the fluorescence intensity of GFP. Substitution of the functional amino 
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acids with glycine residues also affects the expression of the target protein, but the reason 
for this is unclear. Another unresolved question is how to control the expression of LEA 
peptide and target protein inside the cell.  Related to this, the mechanism through which 
the 11aa residue on the LEA peptide enhances the target protein expression requires 
further study. The importance of repeating length and functional residues in the design of 
LEA peptides is not clear in previous studies. 
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Figure 1.7 Time dependence of GFP expression after IPTG induction by co-
expression with LEA peptide in E.coli.  
doi:10.1371/journal.pone.0082824.g001  
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Figure 1.8 Relative GFP expression and mRNA, with co-expression of each repeated 
LEA peptide 4 h after induction. (a) Relative GFP expression levels and (b) mRNA 
levels with co-expression of each repeated LEA-like peptide 4 h after induction. The 
co-expressed LEA peptide were as follows: 1 repeat, 2 repeats, 3 repeats, 4 repeats 
and 6 repeats. 
doi:10.1371/journal.pone.0082824.g002 
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Figure 1.9 GFP expression with co-expression of each LEA peptide. (a) The designed 
sequence of each LEA-like peptide (b) Time dependence of GFP expression with co-
expression of each LEA-like peptide (c) GFP expression with co-expression of each 
LEA-like peptide 4 h after induction. Data are expressed as mean 6 s.d. (n = 5). 
Results with * P,0.0001 and ** P,0.005, shown above the bar were significantly 
different from those for GFP alone (two-side t-test). *** did not show significant 
difference from GFP alone (two-side t-test).  
doi:10.1371/journal.pone.0082824.g003 
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1.3 Aim and motivation of thesis  
Co-expression systems are of significant scientific interest due to their huge potential 
application toward the production of desirable recombinant proteins for healthcare and 
medical diagnostics, owing to their ease of handling, eco-friendliness, and utility of such 
small peptides. Biological and biomedical science are throughout used recombinant 
proteins. Their production was once the domain of experts, but the development of 
simple, commercially available systems has made the technology more widespread. As a 
result, a more general appreciation of the questionable, strategic choices inherent to the 
process has emerged. The significant applications of the co-expression system include 
enhancement of the quality and quantity of recombinant proteins in the various fields of 
biological sciences, especially in the food industry, environmental science, drug delivery 
science, protein engineering, and the study of interaction biomolecules, immunology, 
agriculture biology and molecular biology.  
For production of recombinant proteins at an industrial level, different types of co-
expression and expression systems were developed, and are commercially available.   
Despite these successes, these systems have some drawbacks for production of 
recombinant proteins in large quantities at low cost. Some commonly encountered 
questions include which system should the protein(s) be expressed, such as bacteria, 
yeast, insects, or in human cells; as well as which vector should be used for the expression 
of the protein. If bacteria is used as a host for expression, questions arise as to which 
bacterial strain(s) should be chosen for protein expression. An additional consideration is 
whether soluble, fragment, or full-length protein should be expressed. Purification 
strategies, including the technical drawbacks will further inform choices regarding 
expression systems. For example, if the expressed protein should be tagged, the tag 
system most suitable for the protein expression system must be considered. Regrettably, 
because of all proteins are different, and there is no single system available suitable for 
all these requirements, strategies and purification protocols must be devised for each 
protein.  
Considering limitations, such as loss of activity during the production of recombinant 
protein, construction of plasmids, and interference with the purification of recombinant 
protein, analytes should be considered for development of tag-based co-expression 
systems. Commercially available types of tag-based co-expression systems have emerged 
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as potential candidates for the production of recombinant proteins due to their ease of 
handling, the flexibility of use in various applications, fast response, and excellent 
biocompatibility. The technological development of tag-based co-expression systems 
increases the production of recombinant proteins, but due to the time required for protein 
purification and expression analyses, the actual production rate of recombinant protein is 
meager. To overcome these limitations, high-production rate-based co-expression 
systems without loss of recombinant protein at the time of purification is required.  
The current thesis aims to focus on the development of LEA peptide function by design 
and characterization of novel LEA peptides. At first, new LEA peptide sequences are 
applied to achieve efficient expression of the protein, and overcome the problems of 
conventional methods. This method is simple, in that the protein is co-expressed with 
only an 11-amino acid peptide. Also, the separation process for protein purification is 
straightforward, because the co-expressed peptide is minimal. Secondly, LEA protein has 
various functions such as ion sequestration, maintenance of protein and membrane 
structure, nuclear transport, and molecular chaperoning. Hence, novel engineered LEA 
peptides may have many undiscovered functions in E.coli. These results could have a 
considerable impact, not only in applications involving bacterial protein expression but 
also in molecular biology, to provide molecular shields under abiotic stress conditions. 
These results also could help to clarify the function of native LEA peptides in the cell. 
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1.4 Purpose of this study 
 The LEA peptide is hydrophilic, based on the receptivity of the 11mer amino acid 
residue in P. vanderplanki larvae. Using LEA peptide, GFP, GST, CAT, and GUS protein 
were investigated in E. coli to enhance the expression level inside the cell. These proteins 
were co-expressed not only at a high level in the soluble and active form in bacteria, but 
also easily purified from the target protein to near homogeneity, in a single step using the 
affinity elution of the target protein. In the previous study, the length or the position of 
amino acids in the LEA peptide sequence have not been optimized. Also, control of the 
expression level of LEA peptide and target protein have not been thoroughly studied. The 
functional properties of the LEA peptide inside the cell have not been characterized. The 
most important consideration is that a functional mechanism remains unknown.  
In this study, the following in vivo experiments were performed to elucidate LEA 
peptide function (Figure 1.10). The function of LEA peptide was developed by codon 
optimization in the LEA peptide sequence through mutation, addition, and deletion of 
amino acids and change of C- and N-terminal amino acids in the LEA peptide. Through 
a dual expression method, the role of the LEA peptide was investigated by controlled 
peptide expression. Then, the functional properties of the LEA peptide against abiotic 
stress were studied. Through these experiments and results, the purpose of this research 
is to help clarify the mechanism of LEA peptide function in E. coli.   
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Figure 1.10 Schematic diagram of this study 
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1.5 Thesis organization 
 
This thesis studies the role and function of LEA peptide in the host cell through a co-
expression system. The nature, position, and length of the amino acid sequence of the 
LEA peptide was the main focus of this study. The effort has been made to utilize this co-
expression system at an industrial level, and enhance the quality and quantity of 
recombinant protein inside the cell. Also, the function of LEA peptide under the abiotic 
stresses was also investigated.  
 
The first chapter describes the bioactive peptides and LEA proteins, and the protein 
expression system refers to the way in which recombinant proteins are synthesized, 
modified and regulated in living organisms. The bioactive peptides are biologically and 
synthetic and their use is a different kind, by industrial, pharmaceutical and medical 
purposes. In this chapter, types of LEA proteins and design strategy of LEA peptides is 
also discussed. In recombinant protein production research, the term can apply to either 
the object of study or the laboratory techniques required to manufacture proteins. It is 
focused on the latter meaning of protein production and expression in different kind of 
host cells. However, in practical terms, recombinant protein production depends on using 
cellular machinery.  
 
In the second chapter the role and position of amino acids in the LEA peptide sequence 
is determined by the development of an efficient recombinant protein expression system. 
Peptide sequences were designed by mutating the amino acids in a LEA peptide 
constructed in a previous study (LEA-I). In the amino acid sequence of the 13-mer LEA 
peptide, glycine at the sixth and twelfth positions was replaced with functional amino 
acids via point mutations. For optimization of LEA peptide length, various lengths of 
LEA peptide, between 5aa to 24aa, were designed and constructed for expression. The 
role of the C-terminal and N-terminal amino acids in the LEA peptide sequence, were 
examined using LEA peptide mutants.  
 
The third chapter examines the dual expression system to analyze the efficiency of 
expression of LEA peptide by using a time-independent process for control of the inducer 
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of expression of the LEA peptide co-expression system. In this chapter, the concentration 
of inducer Isopropyl-thio-β-D-galactopyranoside (IPTG) and Arabinose (Arb), inducing 
time, and the effect of dual expression on the production of recombinant protein was 
investigated. 
 
The fourth chapter deals with the application and function of the LEA peptide co-
expression system under abiotic stress. In vivo functional analyses of the LEA peptide 
expressed in recombinant BL 21 (DE3) in E. coli were carried out under abiotic stress 
(salt, heat, and cold) conditions. LEA peptide was derived from the P. vanderplanki group 
3 LEA proteins, based on distinctive conserved amino acid motif sequences. High-salt 
(5% and 7% NaCl) concentrations and heat (48°C) and cold (4°C) stress were used to 
evaluate the functional relevance of the peptide under abiotic salt stress.  
   
In the fifth chapter, I summarized all results and concluded with the hypothesis and 
prospects of this study.  
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Objectives 
 
The aim of this study: 
 
     1: To enhance the protein expression through co-expression system by a mutation 
in the LEA peptide. (2nd Chapter) 
 
     2: To evaluate the role of LEA peptide length in the protein co-expression 
(Increase, decrease and change C-terminal amino acid of LEA peptide).  
(2nd Chapter) 
 
     3: To observe the function of LEA peptide dual expression system for the 
expression of recombinant protein in the E.coli cells. (3rd Chapter) 
 
     4: To analyze the function of LEA peptide against abiotic stress in E.coli  
(4th chapter) 
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Chapter 2: Role of amino acids in LEA peptide to enhance the 
protein expression through co-expression system determine 
 
 
2.1 Introduction 
 
The recombinant protein is one of a quirky and auspicious technique for the 
improvement of basic daily life sciences(Cregg et al., 2000; Makrides, 1996). A wide 
range of new possibilities come to produce and purify the desired recombinant protein for 
industrial processes, or its use to diagnose or treat genetic disease. Outwardly, it is not to 
be a quite simple and amazing to express the recombinant protein in the host cell(Demain 
and Vaishnav, 2009; Schein, 1989). The desired to produce recombinant protein 
primarily, it encodes the DNA for the target protein in an expression vector through 
downstream of a promoter(Baneyx and Mujacic, 2004; Ross et al., 1998). To provide the 
desired protein, introduce vector into a transformant, and induce the cell’s protein 
synthesis machinery. The E.coli expression system is widely used for the production and 
expression of the recombinant protein (Baneyx, 1999; Cregg et al., 2000; Makrides, 
1996). 
Now a day’s researcher focusses on the quality and as well as quantity improvement of 
recombinant protein into the lower and higher organisms through the recombinant DNA 
technology for the achievement of high yield(Demain and Vaishnav, 2009; Houdebine, 
2009; Summers, 1998). In practice, however, protein expression system is very 
challenging because so many factors may influence the bioprocess to produce 
recombinant desire protein(Rosano and Ceccarelli, 2014). For example, each protein 
folds in its unique manner, a process that may be controlled by choice of host for the 
expression of the protein (Chen, 2012; La Grange et al., 2010; Swartz, 2001). Similarly, 
some proteins enforce proper insertion and post-translational modifications into a 
biological transmembrane. Protein expression systems are used in life sciences, 
biotechnology, and medicine (Chen, 2012; Gerngross, 2004; Qing et al., 2004; Rosano 
and Ceccarelli, 2014; Wurm, 2004). These methods can be cell-based or cell-free. Finally, 
some recombinant proteins may have an enterprise that is detrimental to the transformant. 
Thus, no single solution exists for the all recombinant protein production (Korhonen and 
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Pihlanto, 2006; Rosano and Ceccarelli, 2014; Wurm, 2004). Instead, it is constructive to 
have access to a broad spectrum of expression tools, and a better one’s chances of success 
willingness to explore multiple approaches. At present, for research and development on 
proteins, recombinant technology is used for protein production and expression in host 
cells. Furthermore, the creation of such recombinant biological proteins mainly focuses 
on the development of new biologically active peptides and protein drugs(Morris et al., 
2001; Torchilin and Lukyanov, 2003). 
The development of techniques to exclude disturbances in protein expression can 
facilitate the large-scale production of functional biological proteins(Junge et al., 2008; 
Von Mering et al., 2002). Many researchers have aimed at developing efficient techniques 
for the global production of biologically functionally active proteins(Hammer et al., 1981; 
Mukhopadhyay, 1997). The production of a variety of recombinant proteins and peptide 
sequences uses E. coli as the host(Demain and Vaishnav, 2009; Schein, 1989). For the 
production achievement at the large scale, I focus on the biotic and abiotic parameter, 
recombinant cells, and growth curve. E. coli is the best understood and developed 
microorganism for producing high levels of several recombinant biological proteins.  
The approaches include the optimization and escalation of culture conditions. The 
molecular chaperones use in the different type of co-express system for target protein 
expression(Hunt, 2005; Martin et al., 2001). Maltose-binding protein or glutathione S-
transferase and chitin-binding protein are used for the detection, purification, and 
quantitation of recombinant biologically active proteins for achieving efficient production 
as a fusion tag protein(Einhauer and Jungbauer, 2001; Terpe, 2003). These are effective 
and conventional protein production methods. However, simple yet effective and efficient 
universal approaches for enhancing protein expression still investigate for applications in 
a broad spectrum of research and development fields and applications (Andersen and 
Krummen, 2002; Baneyx, 1999; Sørensen and Mortensen, 2005a). 
Divergent families of LEA proteins have been identified and cloned from many plants, 
animal, and insect species (Battaglia et al., 2008; Furuki et al., 2012; Furuki et al., 2011; 
Gal et al., 2004; Goyal et al., 2005b; Grelet et al., 2005; Hatanaka et al., 2015; Kikawada 
et al., 2006; Liu et al., 2013; Shimizu et al., 2010; Wolkers et al., 2001). Most of these 
LEA proteins are cytosolic and hydrophilic and contain random coils or α-helices. LEA 
proteins have been identified and classified into six different groups by the presence of 
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amino acid sequence homology and specific motifs(Dure et al., 1989). They are low-
molecular-weight proteins ranging from 10 to 30 kDa and sometimes above 30 (Hong-
Bo et al., 2005). Desiccation stress and plant hormone abscisic acid play a role in the 
expression of LEA mRNA and protein which advocates its protecting role for plant 
structures during water loss(Curry et al., 1991). Increased concentration of purified group 
1 LEA protein, increased lactate dehydrogenase activity retained after desiccation which 
shows the protective properties of LEA protein also depends on the target enzyme. Group 
3 (G3) LEA proteins are classified by the presence and expression of a particular 
repeating sequence of 11 amino acids. G3LEA proteins have some unusual properties 
unlike many globular proteins: while they are intrinsically disordered in solution, upon 
desiccation, they can develop a secondary structure, often predominantly α-helical, as 
shown for various G3LEA proteins originating from nematodes, pea mitochondria Typha 
latifolia pollen, and Polypedilum vanderplanki larvae(Battaglia et al., 2008; Furuki et al., 
2012; Furuki et al., 2011; Gal et al., 2004; Goyal et al., 2005b; Grelet et al., 2005; 
Hatanaka et al., 2015; Kikawada et al., 2006; Liu et al., 2013; Shimizu et al., 2010; 
Wolkers et al., 2001).  
 
To achieve large-scale of efficient protein expression, I focused on the protein co-
expression system derived from the properties of LEA proteins. With the vast applications 
of these features, I presupposed that the LEA protein-motif peptide (LEA peptide) might 
play a similar role in the anti-aggregation of expressed protein within the cell and enhance 
protein expression. Previously, in LEA peptide, charged and hydrophobic amino acids 
were changed with Glycine in LEA peptide which strengthened hypothesis that not only 
charged amino acids but also hydrophobic amino acids in the peptide sequence are 
essential to enhance protein expression when using the LEA peptide co-expression 
system. From these results, it summarize that hydrophobic residues of the LEA peptide 
allow attachment to the protein surface, and the charged residues inhibit protein 
aggregation in the cell by their electrostatic charge(Ikeno and Haruyama, 2013).  
In this chapter, to increase the expression of the protein and developed a new expression 
system through LEA peptide, point mutations were introduced into the LEA peptides. 
Through point mutations, glycine at positions 6th and 12th in a previously constructed 
LEA peptide were substituted with glutamic acid, lysine, leucine, asparagine, or serine. 
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The selected amino acids were based on some repetitive amino acids in the group 3 LEA 
proteins (PvLEA1, PvLEA2, and PvLEA3) of P. vanderplanki larvae(Kikawada et al., 
2006). The length of LEA peptide is also an important factor for LEA peptide function. 
The optimal LEA peptide length was investigated. The role of C-and N-terminus amino 
acid in the LEA peptide sequence for the co-expression system also study. The obtained 
result will be useful information not only to develop efficient protein expression using 
the system, but also to study important data for hypothesis verification of LEA peptide 
function.  
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2.2 Materials and methods 
 
2.2.1 Peptides design and sequences 
2.2.1.1 Design of mutated LEA peptide 
  Point mutations were introduced into previously constructed LEA peptide based on 
G3LEA proteins of Polypedilum vanderplanki. The original constructed sequence is 
Met(M)-Asp(D)-Ala(A)-Lys(K)-Asp(D)-Gly(G)-Thr(T)-Lys(K)-Glu(E)-Lys(K)-
Ala(A)-Gly(G)-Glu(E) (Ikeno and Haruyama, 2013).  
The glycine at positions 6th and 12th were replaced with serine, asparagine, leucine, 
lysine, and glutamic acid to generate the following LEA peptides: LEA-S 13aa, LEA-N 
13aa, LEA-L 13aa, LEA-K 13aa, and LEA-E 13aa, respectively (Table 2.1).  
 
Table 2.1 LEA (late embryogenesis abundant) peptide sequence 
 
 
2.2.1.2 Deletion of the 2nd D on mutated LEA peptide at N-terminus 
The second D into previously constructed LEA peptide and mutated LEA peptide was 
deleted. The following LEA peptides: LEA-S 12aa, LEA-N 12aa, LEA-L12aa, LEA-K 
12aa, and LEA-E 12aa LEA-I 12aa and LEA-II 12aa, respectively (Table2.2).  
 
Table 2.2 Deletion of the 2nd D in LEA peptide 
 
  
S.No LEA peptide Sequence 
1 LEA I 13aa MDAKDGTKEKAGE 
2 LEA II 13aa MDAKDGLKEKAGE 
3 LEA E 13aa MDAKDETKEKAEE 
4 LEA K 13aa MDAKDKTKEKAKE 
5 LEA L 13aa MDAKDLTKEKALE 
6 LEA N 13aa MDAKDNTKEKANE 
7 LEA S 13aa MDAKDSTKEKASE 
S.No LEA peptide Sequence 
1 LEA I 12aa MAKDGTKEKAGE 
2 LEA II 12aa MAKDGLKEKAGE 
3 LEA E 12aa MAKDETKEKAEE 
4 LEA K 12aa MAKDKTKEKAKE 
5 LEA L 12aa MAKDLTKEKALE 
6 LEA N 12aa MAKDNTKEKANE 
7 LEA S 12aa MAKDSTKEKASE 
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2.2.1.3 Design of various length of LEA peptides  
Point mutations were introduced into previously constructed mutated LEA-K13aa at 7th 
position and change Threonine (T) to Leucine (L) amino acid. The mutated new LEA-K 
13aa sequence is Met(M)-Asp(D)-Ala(A)-Lys(K)-Asp(D)-Lys(K)-Thr(T)-Lys(K)-
Glu(E)-Lys(K)-Ala(A)-Lys(k)-Glu(E).  
The amino acid in LEA-K (T-L) 13aa peptide sequence was increased and decreased for 
the design of various length of LEA peptide (LEAK (new)). Table 2.3 and Table 2.4 
shows the sequence of various length of LEA peptide adding one by one amino acid and 
delete one by one amino acid. 
 
Table 2.3 Increase of the length of LEA peptide sequence 
S.No LEA peptide Sequence 
1 LEA I MDAKDGTKEKAGE 
2 LEA K MDAKDKTKEKAKE 
3 LEA K(new) MDAKDKLKEKAKE 
4 LEA K (14) MDAKDKLKEKAKEA 
5 LEA K (15) MDAKDKLKEKAKEAK 
6 LEA K (16) MDAKDKLKEKAKEAKD 
7 LEA K (17) MDAKDKLKEKAKEAKDK 
8 LEA K (18) MDAKDKLKEKAKEAKDKL 
9 LEA K (19) MDAKDKLKEKAKEAKDKLK 
10 LEA K (20) MDAKDKLKEKAKEAKDKLKE 
11 LEA K (21) MDAKDKLKEKAKEAKDKLKEK 
12 LEA K (22) MDAKDKLKEKAKEAKDKLKEKA 
13 LEA K (23) MDAKDKLKEKAKEAKDKLKEKAK 
14 LEA K (24) MDAKDKLKEKAKEAKDKLKEKAKE 
  
Table 2.4 Decrease of the length of LEA peptide 
S.No LEA peptide Sequence 
1 LEA I MDAKDGTKEKAGE 
2 LEA K (13) MDAKDGLKEKAGE 
3 LEA K(12) MDAKDGLKEKAG 
4 LEA K (11) MDAKDGLKEKA 
5 LEA K (10) MDAKDGLKEK 
6 LEA K (9) MDAKDGLKE 
7 LEA K (8) MDAKDGLK 
8 LEA K (7) MDAKDKL 
9 LEA K (6) MDAKDK 
10 LEA K (5) MDAKD 
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2.2.1.4 Change of C-terminus amino acid at position 23rd on long LEA peptide 
Point mutations were introduced at C-terminus amino acids on LEA-K (23). The original 
constructed sequence is Met(M)-Asp(D)-Ala(A)-Lys(K)-Asp(D)-Lys(K)-Leu(L)-
Lys(K)-Glu(E)-Lys(K)-Ala(A)-Lys(k)-Glu(E)-Ala(A)-Lys(K)-Asp(D)-Lys(K)-Leu(L)-
Lys(K)-Glu(E)-Lys(K)-Ala(A)-Lys(K). 
The Lyisne (K) at positions 23rd position was replaced with alanine (A), aspartic acid 
(D), glutamic acid (E), glycine (G), leucine (L), asparagine (N), glutamine (Q), arginine 
(R), serine (S), valine(V) and tryptohan (W) to generate the new LEA peptides (Table2.5). 
 
Table 2.5 Change of C-terminus of LEA K (23) 
S.No LEA peptide LEA peptide sequence 
1 LEA I MDAKDKLKEKAKE 
2 LEA K (23) MDAKDKLKEKAKEAKDKLKEKAK 
3 LEA K(A) MDAKDKLKEKAKEAKDKLKEKAA 
4 LEA K (D) MDAKDKLKEKAKEAKDKLKEKAD 
5 LEA K (E) MDAKDKLKEKAKEAKDKLKEKAE 
6 LEA K (G) MDAKDKLKEKAKEAKDKLKEKAG 
7 LEA K (L) MDAKDKLKEKAKEAKDKLKEKAL 
8 LEA K (N) MDAKDKLKEKAKEAKDKLKEKAN 
9 LEA K (Q) MDAKDKLKEKAKEAKDKLKEKAQ 
10 LEA K (R) MDAKDKLKEKAKEAKDKLKEKAR 
11 LEA K (S) MDAKDKLKEKAKEAKDKLKEKAS 
12 LEA K (V) MDAKDKLKEKAKEAKDKLKEKAV 
13 LEA K (W) MDAKDKLKEKAKEAKDKLKEKAW 
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2.2.2 Plasmid construction for E. coli transformation 
pRSF Duet-1 plasmid (Novagen Merck KGaA, Darmstadt, Germany) was used as an 
expression vector for the co-expression of green fluorescence protein (GFP) and LEA 
peptide. pRSF Duet-1 contains two multiple cloning sites, namely, MCS1 and MCS2, 
together with ribosome-binding sites and a T7 lac promoter vector. MCS1 and MCS2 
cloning sites were subcloned with GFP and LEA genes, respectively. At the cloning site 
of MCS1, GFP was subcloned into the BamHI and HindIII site of pRSF Duet-1 as 
described previously. The construction of the expression vector was verified by DNA 
sequencing using FASMAC (Atsugi, Japan). All the oligo-DNAs for LEA gene were 
obtained from Eurofins (Tokyo, Japan) (Ikeno and Haruyama, 2013). 
 
 
Figure 2.1 pRSF Duet plasmid 
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2.2.2.1 Plasmid construction of mutated LEA peptide 
  The gene encoding LEA-I was subcloned into the expression vector as described 
previously(Ikeno and Haruyama, 2013). The oligo-DNAs were phosphorylated at 37°C 
for one h by using T4 polynucleotide kinase (New England Biolabs), followed by 
treatment at 65°C for 20 min. Each pair (S and AS) was then hybridized in Tris-HCl 
buffer (pH 8.0) containing 50 mM KCl. LEA peptide genes LEA-E, LEA-K, LEA-L, LEA-
N, and LEA-S were subcloned into the pRSF Duet-1 vector digested by the restriction 
enzymes EcoRV and XhoI (New England Biolabs, MA, USA). The following oligo-DNA 
pairs in Table 2.6 encoded these LEA peptides.  
 
Table 2.6 DNA for construction of mutated LEA peptide gene 
S.No DNA name Sequence 
1 S-LEA-E 5ʹ-GCGAAAGACGAAACGAAAGAAGCAGAAGAA 
TAAC-3ʹ 
2 AS-LEA-E 5ʹTCGAGTTATTCTTCTGCTTTTTCTTTCGTTTCGTCTTT
CGC-3ʹ 
3 S-LEA-K 5ʹ-GCGAAAGACAAAACGAAAGAAGCAAAAGAA 
TAAC-3ʹ 
4 AS-LEA-K 5ʹTCGAGTTATTCTTTTGCTTTTTCTTTCGTTTTGTCTTT 
CGC-3ʹ 
5 S-LEA-L 5ʹ-GCGAAAGACTTGACGAAAGAAGCATTGGAA 
TAAC-3ʹ 
6 AS-LEA-L 5ʹTCGAGTTATTCCAATGCTTTTTCTTTCGTCAAGTCTTT
CGC-3ʹ 
7 S-LEA-N 5ʹ-GCGAAAGACAATACGAAAGAAGCAAATGAA 
TAAC-3ʹ 
8 AS-LEA-N 5ʹ-TCGAGTTATTCATTTGCTTTTTCTTTCGTATTGTCTTT 
CGC-3ʹ 
9 S-LEA-S 5ʹ-GCGAAAGACTCTACGAAAGAAGCATCTGAA 
TAAC-3ʹ 
10 AS-LEA-S 5ʹ-TCGAGTTATTCAGATGCTTTTTCTTTCGTAGAGTCTTT 
CGC-3ʹ 
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2.2.2.2 Deletion of 2nd D in LEA peptide 
The oligo-DNAs were phosphorylated at 37°C for 1h by using T4 polynucleotide kinase 
(New England Biolabs), followed by treatment at 65°C for 20 min. Each pair was then 
hybridized in Tris-HCl buffer (pH 8.0) containing 50 mM KCl. Mutated LEA peptides 
deleted 2nd D from the N-terminus were subcloned into the pRSF Duet-1 vector digested 
by the restriction enzymes NdeI and XhoI (New England Biolabs, MA, USA). The 
following oligo-DNA pairs in Table 2.7 encoded these LEA peptides. 
 
Table 2.7 DNA for construction of mutated LEA peptide gene (deletion 2nd) 
S.No DNA name Sequence 
1 S-LEA-I(12) 5ʹ- TATGGCGGACGAAACGAAAGAAGCAGAAGAA 
TAAC -3ʹ 
2 AS-LEA-I(12) 5ʹ- TCGAGTTATTCTTCTGCTTTTTCTTTCGTTTCGT 
CCGCAC -3ʹ 
3 S-LEA-E(12) 5ʹ-TATGGCGGACGAAACGAAAGAAGCAGAAGAA 
TAAC-3ʹ 
4 AS-LEA-
E(12) 
5ʹ- TCGAGTTATTCTTCTGCTTTTTCTTTCGTTTCGT 
CCGCCA-3ʹ 
5 S-LEA-K(12) 5ʹ-TATGGCGGACAAAACGAAAGAAGCAAAAGAA 
TAAC-3ʹ 
6 AS-LEA-
K(12) 
5ʹ- TCGAGTTATTCTTTTGCTTTTTCTTTCGTTTTGT 
CCGCCA-3ʹ 
7 S-LEA-L(12) 5ʹ-TATGGCGGACTTGACGAAAGAAGCATTGGAA 
TAAC-3ʹ 
8 AS-LEA-
L(12) 
5ʹ- TCGAGTTATTCCAATGCTTTTTCTTTCGTCAAGT 
CCGCCA-3ʹ 
9 S-LEA-N(12) 5ʹ-TATGGCGGACAATACGAAAGAAGCAAATGAA 
TAAC-3ʹ 
10 AS-LEA-
N(12) 
5ʹ- TCGAGTTATTCATTTGCTTTTTCTTTCGTATTGT 
CCGCCA-3ʹ 
11 S-LEA-S(12) 5ʹ-TATGGCGGACTCTACGAAAGAAGCATCTGAA 
TAAC-3ʹ 
12 AS-LEA-
S(12) 
5ʹ- TCGAGTTATTCAGATGCTTTTTCTTTCGTAGAGT 
CCGCCA-3ʹ 
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2.2.2.3 Construction of mutated new LEA K(T-L)13aa  
Point mutations were introduced into previously constructed mutate LEA K peptide and 
change the 7th position of threonine (T) to leucine (L). The oligo-DNAs were 
phosphorylated at 37°C for 1 h by using T4 polynucleotide kinase (New England 
Biolabs), followed by treatment at 65°C for 20 min. Each pair was then hybridized in 
Tris-HCl buffer (pH 8.0) containing 50 mM KCl. The following oligo-DNA pairs in 
Table 2.8 encoded these LEA peptides. Mutated LEA K peptide sequence was subcloned 
into the pRSF Duet-1 vector digested by the restriction enzymes EcoRV and XhoI (New 
England Biolabs, MA, USA). 
 
2.2.2.4 Construction of long LEA peptide expression vector 
DNA for construction of various length of LEA K peptide gene (14-16 amino acids) 
To increase the length of LEA peptide, the amino acid was added one by one in the new 
mutated LEA K. The oligo-DNAs were phosphorylated at 37°C for 1 h by using T4 
polynucleotide kinase (New England Biolabs), followed by treatment at 65°C for 20 min. 
Each pair was then hybridized in Tris-HCl buffer (pH 8.0) containing 50 mM KCl. The 
hybridized DNA fragments were ligated with the vector, digested by the restriction 
enzymes EcoRV and XhoI. The oligo-DNAs for this construction are shown in Table 2.8. 
 
DNA for construction of various length of LEA K peptide gene (17-24 amino acids) 
To increase the length of LEA peptide, the amino acid was added one by one in the new 
mutated LEA K. The oligo-DNAs were phosphorylated at 37°C for 1 h by using T4 
polynucleotide kinase (New England Biolabs), followed by treatment at 65°C for 20 min. 
Each pair was then hybridized in Tris-HCl buffer (pH 8.0) containing 50 mM KCl. The 
hybridized DNA fragments were ligated with the vector (LEAK-AKDI) digested by the 
restriction enzymes EcoRV and XhoI. The oligo-DNAs for this construction are shown in 
Table 2.9.  
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Table 2.8 DNA for construction of various length of LEA K peptide gene (13-16) 
S.No DNA name Sequence 
1 S-LEA-K 
(T-L) 
5ʹ- GCGAAAGACAAACTGAAAGAAAAAGCAAAA 
GAAtaa-3ʹ 
2 AS-LEA-K 
(T-L) 
5ʹ- 
tcgattaTTCTTTTGCTTTTTCTTTCAGTTTGTCTTTCGC-3ʹ 
3 S-LEA-K 
(14) 
5ʹ- GCGAAAGACAAACTGAAAGAAAAAGCAAAAG 
AAGCGCtaa-3ʹ 
4 AS-LEAK 
(14) 
5ʹ- tcgattaCGCTTCTTTTGCTTTTTCTTTCAGTTTGTCTT 
TCGC-3ʹ 
5 S- LEA-K 
(15) 
5ʹ- GCGAAAGACAAACTGAAAGAAAAAGCAAAA 
GAAGCG 
AAAtaa-3ʹ 
6 AS-LEA-K 
(15) 
5ʹ- tcgattaTTTCGCTTCTTTTGCTTTTTCTTTCAGTTTG 
TCTTTCGC-3ʹ 
7 S-LEA-K 
(16) 
5ʹ- GCGAAAGACAAACTGAAAGAAAAAGCAAAA 
GAAGCGAAAGATtaa-3ʹ 
8 AS-LEA-
K(16) 
5ʹ-tcgattaATCTTTCGCTTCTTTTGCTTTTTCTTTCAG 
TTTGTCTTTCGC-3ʹ 
9 S-LEAK 
(AKDI) 
5ʹ-GCGAAAGACAAACTGAAAGAAAAAGCAAAA 
GAAGCGAAAGATATCtaa-3ʹ 
10 AS-LEA-K 
(AKDI) 
5ʹ- tcgattaGATATCTTTCGCTTCTTTTGCTTTTTCTTT 
CAGTTTGTCTTTCGC-3ʹ 
 
 
Table 2.9 DNA for construction of various length of LEA K peptide gene (17-24) 
S.No DNA name Sequence 
1 S-LEA-K(17) 5ʹ-AAGtaac-3ʹ 
2 AS-LEA-K(17) 5ʹ-tcgagttaCTT-3ʹ 
3 S-LEA-K(18) 5ʹ- AAGTTGtaac-3ʹ 
4 AS- LEA-K(18) 5ʹ-tcgagttaCAACTT-3ʹ 
5 S- LEA-K(19) 5ʹ-AAGTTGAAGtaac-3ʹ 
6 AS-LEA-K(19) 5ʹ-tcgagttaCTTCAACTT-3ʹ 
7 S-LEA-K(20) 5ʹ-AAGTTGAAGGAGtaac-3ʹ 
8 AS-LEA-K(20) 5ʹ-tcgagttaCTCCTTCAACTT-3ʹ 
9 S-LEA-K(21) 5ʹ-AAGTTGAAGGAGAAGtaac-3ʹ 
10 AS-LEA-K(21) 5ʹ-tcgagttaCTTCTCCTTCAACTT-3ʹ 
11 S-LEA-K(22) 5ʹ-AAGTTGAAGGAGAAGGCCtaac-3ʹ 
12 AS-LEA-K(22) 5ʹ-tcgagttaGGCCTTCTCCTTCAACTT-3ʹ 
13 S-LEA-K(23) 5ʹ-AAGTTGAAGGAGAAGGCCAAGtaac-3ʹ 
14 AS-LEA-K(23) 5ʹ-tcgagttaCTTGGCCTTCTCCTTCAACTT-3ʹ 
15 S-LEA-K(24) 5ʹ-AAGTTGAAGGAGAAGGCCAAGGAGtaac-3ʹ 
16 AS-LEA-K(24) 5ʹ-tcgagttaCTCCTTGGCCTTCTCCTTCAACTT-3ʹ 
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2.2.2.5 Construction of short LEA peptide expression vector  
 To decrease the length of new mutated LEA K peptide. The oligo-DNA pair was then 
hybridized in Tris-HCl buffer (pH 8.0) containing 50 mM KCl. Short LEA peptides gene 
were subcloned into the pRSF Duet-1 vector digested by the restriction enzymes EcoRV 
and XhoI (New England Biolabs, MA, USA). The following oligo-DNA pairs in Table 
2.10 encoded these LEA peptides. 
 
 
Table 2.10 DNA for construction of various length of LEA K peptide gene (5-12) 
S.No DNA name Sequence 
1 S-LEA-K(12) 5ʹ-GCGAAAGACAAACTGAAAGAAAAAGC 
AAAAtaac-3ʹ 
2 AS-LEA-K(12) 5ʹ-tcgagttaTTTTGCTTTTTCTTTCAGTTTGTCTTT 
CGC -3ʹ 
3 S-LEA-K(11) 5ʹ-GCGAAAGACAAACTGAAAGAAAAAGCAtaac-3ʹ 
4 AS- LEA-K(11) 5ʹ-tcgagttaTGCTTTTTCTTTCAGTTTGTCTTTCGC -3ʹ 
5 S- LEA-K(10) 5ʹ-GCGAAAGACAAACTGAAAGAAAAAtaac-3ʹ 
6 AS-LEA-K(10) 5ʹ-tcgagttaTTTTTCTTTCAGTTTGTCTTTCGC -3ʹ 
7 S-LEA-K(9) 5ʹ-GCGAAAGACAAACTGAAAGAAtaac-3ʹ 
8 AS-LEA-K(9) 5ʹ-tcgagttaTTCTTTCAGTTTGTCTTTCGC -3ʹ 
9 S-LEA-K(8) 5ʹ-GCGAAAGACAAACTGAAAtaac-3ʹ 
10 AS-LEA-K(8) 5ʹ-tcgagtta TTTCAGTTTGTCTTTCGC-3ʹ 
11 S-LEA-K(7) 5ʹ-GCGAAAGACAAACTGtaac-3ʹ 
12 AS-LEA-K(7) 5ʹ-tcgagttaCAGTTTGTCTTTCGC -3ʹ 
13 S-LEA-K(6) 5ʹ-GCGAAAGACAAAtaac-3ʹ 
14 AS-LEA-K(6) 5ʹ-tcgagttaTTTGTCTTTCGC-3ʹ 
15 S-LEA-K(5) 5ʹ-GCGAAAGACtaac-3ʹ 
16 AS-LEA-K(5) 5ʹ-tcgagttaGTCTTTCGC-3ʹ 
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2.2.2.6 Change of C-terminus in LEA peptide 
C-terminus at length of LEA peptide at the 23rd position was introduced mutation with 
other amino acids. The oligo-DNAs for this construction are shown in Table 2.11. The 
oligo-DNAs were phosphorylated at 37°C for 1 h by using T4 polynucleotide kinase 
(New England Biolabs), followed by treatment at 65°C for 20 min. Each pair was then 
hybridized in Tris-HCl buffer (pH 8.0) containing 50 mM KCl. The hybridized DNA 
fragments were ligated with the vector (LEAK-AKDI) digested by the restriction 
enzymes EcoRV and XhoI. The following oligo-DNA pairs in Table 2.11 encoded these 
LEA peptides. 
 
Table 2.11 DNAs for construction of mutation LEA K peptide in C terminus gene 
S.No DNA name Sequence 
1 S-LEA K(A) 5ʹ-AAGTTGAAGGAGAAGGCCGCGtaac-3ʹ 
2 AS-LEA K(A) 5ʹ-tcgagttaCGCGGCCTTCTCCTTCAACTT-3ʹ 
3 S-LEA-K(D) 5ʹ-AAGTTGAAGGAGAAGGCCGACtaac-3ʹ 
4 AS- LEA-K(D) 5ʹ-tcgagttaGTCGGCCTTCTCCTTCAACTT-3ʹ 
5 S- LEA-K(E) 5ʹ-AAGTTGAAGGAGAAGGCCGAAtaac-3ʹ 
6 AS-LEA-K(E) 5ʹ-tcgagttaTTCGGCCTTCTCCTTCAACTT-3ʹ 
7 S-LEA-K(G) 5ʹ-AAGTTGAAGGAGAAGGCCGGTtaac-3ʹ 
8 AS-LEA-K(G) 5ʹ-tcgagttaACCGGCCTTCTCCTTCAACTT-3ʹ 
9 S-LEA-K(L) 5ʹ-AAGTTGAAGGAGAAGGCCTTGtaac-3ʹ 
10 AS-LEA-K(L) 5ʹ-tcgagttaCAAGGCCTTCTCCTTCAACTT-3ʹ 
11 S-LEA-K(N) 5ʹ-AAGTTGAAGGAGAAGGCCAATtaac-3ʹ 
12 AS-LEA-K(N) 5ʹ-tcgagttaATTGGCCTTCTCCTTCAACTT-3ʹ 
13 S-LEA-K(Q) 5ʹ-AAGTTGAAGGAGAAGGCCCAGtaac-3ʹ 
14 AS-LEA-K(Q) 5ʹ-tcgagttaCTGGGCCTTCTCCTTCAACTT-3ʹ 
15 S-LEA-K(R) 5ʹ-AAGTTGAAGGAGAAGGCCCGCtaac-3ʹ 
16 AS-LEA-K(R) 5ʹ-tcgagttaGCGGGCCTTCTCCTTCAACTT-3ʹ 
17 S-LEA-K(S) 5ʹ-AAGTTGAAGGAGAAGGCCAGCtaac-3ʹ 
18 AS-LEA-K(S) 5ʹ-tcgagttaGCTGGCCTTCTCCTTCAACTT-3ʹ 
19 S-LEA-K(V) 5ʹ-AAGTTGAAGGAGAAGGCCGTGtaac-3ʹ 
20 AS-LEA-K(V) 5ʹ-tcgagttaCACGGCCTTCTCCTTCAACTT-3ʹ 
21 S-LEA-K(W) 5ʹ-AAGTTGAAGGAGAAGGCCTGGtaac-3ʹ 
22 AS-LEA-K(W) 5ʹ-tcgagttaCCAGGCCTTCTCCTTCAACTT-3ʹ 
22 AS-LEA-K(W) 5ʹ-tcgagttaCCAGGCCTTCTCCTTCAACTT-3ʹ 
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2.2.3 Strains and culture conditions  
E. coli strains Nova Blue and BL21(DE3) were used for the construction of plasmids 
and the expression of recombinant protein. All cloning was performed using E. coli 
strains grown at 37°C in Luria–Bertani (LB) liquid media supplemented with 50 μg/ml 
kanamycin on plates solidified with 1.5% agar(Ikeno and Haruyama, 2013). 
 
2.2.4 Constitutive co-expression of LEA peptide in E. coli 
The plasmids were transformed in the E. coli strains BL21(DE3) for the co-expression 
of LEA peptide, and target proteins were cultured in LB liquid medium supplemented 
with 50 μg/ml of kanamycin at 37°C about 12 h. The bacterial cultures were diluted 100-
fold using fresh liquid LB medium and allowed to incubate for 2–3 h at 37°C until the 
exponential growth phase (OD600 = 0.5). IPTG was added to the cell cultures at a final 
concentration of 0.1 mM to induce the expression of the inserted gene in recombinants, 
and further grown at 37°C for 8 h. One milliliter of the growing microorganism was 
collected by centrifugation at 1500 ×g for 10 min and suspended with 0.1 M phosphate 
buffer (pH 7.4). Cell growth was detected at an optical density of 600 nm, and GFP 
fluorescence of E. coli was measured at 0, 2, 4, 6, and 8 h by fluorescence spectrometry 
on an FP-6600 instrument (Jasco, Tokyo) at an excitation of 488 nm and emission of 508 
nm (Figure 2.2) (Ikeno and Haruyama, 2013). 
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Figure 2.2 Co-expression of LEA peptide in E. coli 
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2.2.5 Expression and identification of a protein in E. coli by SDS-PAGE analysis 
One milliliter of medium containing E. coli cells and IPTG was collected at 0, 2, 4, 6, 
and 8 h and centrifuged at 1500 ×g for 10 min. The supernatant was discarded and 
suspended in 0.1 M phosphate buffer to adjust for uniform cell number. The soluble 
fraction was mixed with an equal volume of sample loading buffer. The sample mixture 
was heated at 95°C for 5 min and then put on ice for 5 min. Samples were applied on 
12.5% polyacrylamide gel and separated by SDS-PAGE. After electrophoresis, separated 
proteins were visualized by coomassie brilliant blue staining(Ikeno and Haruyama, 2013). 
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2.3 Results 
 
2.3.1 Construction, characterization, and function of mutated LEA peptides 13 and 
12 amino acids 
To analyse the roles of the LEA peptides, LEA-E 13aa, LEA-K 13aa, LEA-L 13aa, 
LEA-N 13aa, and LEA-S13aa were generated by point mutations in the LEA-I sequence 
(Table 2.1) (Ikeno and Haruyama, 2013).  The delete 2nd D at the N-terminus position in 
mutated LEA peptide, LEA-E 12aa, LEA-K12aa, LEA-L 12aa, LEA-N 12aa, and LEA-
S 12aa, LEA-I 12aa and LEA-II 12aa sequence (Table 2.2). The LEA peptide motif is 
characterized by negatively charged residues at positions 2, 5, 9, and 13; positively 
charged residues at positions 4, 8, and 10; and hydrophobic residues at positions 3 and 
11. At first, the 6th and 12th position glycine changed with glutamic acid, lysine, leucine, 
asparagine, and serine to investigate the co-expressed LEA peptide in the cell. The LEA 
peptide encodes a protein of 13 amino acids with a predicted molecular mass of 1379.5–
1523.6 kDa and a pI of 4.36–8.14 (Table 2.12) (Ikeno and Haruyama, 2013). To enhance 
the expression target protein through LEA peptide co-expression system, I also focused 
on the N-terminus position of LEA peptide. The LEA peptide encodes a protein of 12 
amino acids with a predicted molecular mass of 1264.42–1406.66 kDa and a pI of 4.58–
9.40 (Table 2.13). The LEA K 13aa and 12aa the pI value is very high. The corresponding 
LEA peptides were therefore characterized by negatively charged, positively charged, 
hydrophobic, and hydrophilic amino acids, respectively. The size and structure of the 
amino acids in the constructed LEA peptide might play an important role in peptide 
functions. 
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Table 2.12 ExPASY value of 13aa mutated LEA peptide 
S.No LEA peptide 
ExPasy value 
M.W. GRAVY pI value +ve 
charged 
-ve 
charged 
1 LEA I 13aa 1379.5 -1.669 4.78 3 4 
2 LEA E 13aa 1523.6 -2.146 4.36 3 6 
3 LEA K 13aa 1521.7 -2.208 8.14 5 4 
4 LEA L 13aa 1491.7 -1.023 4.78 3 4 
5 LEA N 13aa 1493.6 -2.146 4.78 3 4 
6 LEA S 13aa 1493.5 -1.731 4.78 3 4 
 
 
Table 2.13 ExPASY value of 12aa mutated LEA peptide 
S.No LEA peptide 
ExPasy value 
M.W. GRAVY pI value +ve 
charged 
-ve 
charged 
1 LEA I 12aa 1264.42 -1.517 5.94 3 3 
2 LEA II 12aa 1276.47 -1.142 5.94 3 3 
3 LEA E 12aa 1408.54 -2.033 4.58 3 5 
4 LEA K 12aa 1406.66 -2.100 9.40 5 3 
5 LEA L 12aa 1376.63 -0.817 5.94 3 3 
6 LEA N 12aa 1378.5 -2.033 5.94 3 3 
7 LEA S 12aa 1324.47 -1.583 5.94 3 3 
 
The annotation and description according to the ExPASy. The peptides in the first column 
are used throughout the paper as a shortcut. MW (Da) (Molecular Weight) in Dalton of 
LEA peptides based on amino acids sequence. GRAVY (grand average of hydropathy) 
quantitates the hydrophilicity of the LEA peptides based on amino acid sequence. pI value 
isoelectric point of the LEA peptides based on amino acid composition. 
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2.3.2 Co-expression of the mutated LEA peptide 13 and 12 amino acids to express 
the GFP  
The GFP was selected as a target protein, easy to express and easy to identify at the 
cellular expression level. The evaluation of its expression (fluorescence) is very simple 
to detect without extraction from the cell. To express the GFP as a target protein through 
constructed LEA peptide co-expression system. 
The growth curves of E. coli cells with the pRSF Duet GFP-LEA peptide vector and 
the control containing the empty vector (pRSF Duet GFP) were measured under the same 
conditions after the induction with IPTG. Cells with all the LEA peptide types grew well 
under the same conditions after IPTG induction, as observed at every 2 h of incubation at 
37°C (Figure 2.3.(a)) the cell growth of mutated LEA peptide and (Figure 2.3.(b)) the cell 
growth of deleted 2nd D mutated LEA peptide. 
Figure 2.4 (a) shows the time course of GFP fluorescence with co-expression of each 
muataed LEA peptides containing 13-amino acid units after IPTG induction. The GFP 
fluorescence was effectively increased only when 13 amino acids LEA peptide itself was 
co-expressed in the cell. In contrast, fluorescence intensity decreased in serine congaing 
mutated LEA peptide. The LEA peptides of without 2nd D in the mutated LEA peptide 
the fluorescence intensity decreased with each mutated LEA peptide 12 amino acids 
(Figure 2.4(a). The GFP fluorescence ration between each mutated 12aa and 13aa LEA 
L, LEA N and LEA K show high fluorescence Intensity (Figure 2.5). The expression of 
GFP were also analysed by the SDS-PAGE (Figure 2.6) 
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Figure 2.3 Time dependence of cell growth with the co-expression of each mutated 
LEA peptide ((a): 13aa and (b):12aa) after IPTG induction. Data are mean values 
±SE, with 5 independent repeats. 
(a) 
(b) 
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Figure 2.4 Time dependence of target protein (GFP) expression with the co-
expression of each mutated LEA peptide ((a):13aa, (b):12aa) after IPTG induction. 
The x axes the culture time (hr) after induction IPTG and y axes represent LEA 
peptide expression. analysed with without LEA peptide expression in GFP. Data are 
mean values ±SE, with 5 independent repeats. 
 
 
(a) 
(b) 
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Figure 2.5 Time dependence of target protein (GFP) expression with the co-
expression of each mutated LEA peptide 13aa and 12aa ratio after IPTG induction. 
Data are mean values ±SE, with 5 independent repeats. 
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Figure 2.6 SDS PAGE analysis of expressed GFP. (A) 4hr, and (B) 8hr; analysis of 
expressed GFP in E. coli through the LEA peptide co-expression system. 
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2.3.3 Construction, characterization, and function of the length of LEA peptides 
The function of the length of LEA peptide was determined. The LEA peptide co-
expression system by the fluorescence intensity ratio in E. coli. The sequence of each 
long and short LEA peptide is based on LEA-K (Table 2.3 and 2.4). The co-expression 
of the LEA-I peptide with GFP was used as the control.  The size and structure of the 
amino acids in the constructed LEA peptide might play an important role in peptide 
functions. The LEA peptide encodes a protein of 13 to 24 amino acids with a predicted 
molecular mass of 1533.80–2803.31 kDa and a pI of 8.14–9.63 (Table 2.14).  The LEA 
peptide encodes short chain amino acid by decreasing the amino acid one by one protein 
of 13 to 5 amino acids with a predicted molecular mass of 578.64–1533.80 kDa and a pI 
of 8.14–4.21 (Table 2.15). It was further determined that the percentage of fluorescence 
intensity depends on the charged amino acid residues in the LEA peptide. 
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Table 2.14 ExPASY value of increasing the LEA peptide length by adding one by 
one amino acids 
S.No 
LEA 
peptide 
ExPasy value 
M.W. GRAVY pI value 
+ve 
charged 
-ve  
charged 
1 LEA I 1379.5 -1.669 4.78 3 4 
2 LEA K 1379.5 -1.669 4.78 3 4 
3 LEA K(14) 1533.80 -1.862 8.14 5 4 
4 LEA K (15) 1604.88 -1.600 8.14 5 4 
5 LEA K (16) 1733.06 -1.753 9.30 6 4 
6 LEA K 17) 1848.15 -1.863 8.10 6 5 
7 LEA K (18) 1976.32 -1.982 9.22 7 5 
8 LEA K (19) 2089.48 -1.661 9.22 7 5 
9 LEA K (20) 2217.65 -1.779 9.52 8 5 
10 LEA K (21) 2346.77 -1.865 9.16 8 6 
11 LEA K (22) 2474.94 -1.962 9.46 9 6 
12 LEA K (23) 2546.02 -1.791 9.46 9 6 
13 LEA K (24) 2674.20 -1.883 9.63 10 6 
 
 
Table 2.15 ExPASY value of short chain LEA peptides 
S.No 
LEA 
peptide 
ExPasy value 
M.W. GRAVY pI value 
+ve 
charged 
-ve  
charged 
1 LEA I 1379.5 -1.669 4.78 3 4 
2 LEA K 1533.80 -1.862 8.14 5 4 
3 LEA K(12) 1404.69 -1.725 9.40 5 3 
4 LEA K (11) 1276.51 -1.527 8.19 3 4 
5 LEA K (10) 1205.44 -1.860 8.19 3 4 
6 LEA K (9) 1077.26 -1.633 5.88 3 3 
7 LEA K (8) 948.15 -1.400 8.25 2 3 
8 LEA K (7) 819.97 -1.043 5.71 2 2 
9 LEA K (6) 706.81 -1.850 5.71 2 2 
10 LEA K (5) 578.64 -1.440 4.21 1 2 
 
  The annotation and description according to the ExPASy. The peptides in the first 
column are used throughout the paper as a shortcut. MW (Da) (Molecular Weight) in 
Dalton of LEA peptides based on amino acids sequence. GRAVY (grand average of 
hydropathy) quantitates the hydrophilicity of the LEA peptides based on amino acid 
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sequence. pI value isoelectric point of the LEA peptides based on amino acid 
composition. 
2.3.4 Co-expression of increase and decrease the length of LEA peptides 
The growth curves of E. coli cells with the pRSF Duet GFP-LEA peptide vector and 
the control containing the empty vector (pRSF Duet GFP) were measured under the same 
conditions after the induction with IPTG (Figure 2.7). Cells with all the LEA peptide 
types grew well under the same conditions after IPTG induction, as observed at every 4 
h of incubation at 37°C (Figure 2.8).  
The GFP fluorescence was effectively increased only when 13amino acids LEA 
peptide itself was co-expressed in the cell and till 20 amino acids. The GFP fluorescence 
intensity was stable with the substitution of amino acids with increase the length of LEA 
K peptide length (Figure 2.9 (a-f)). In contrast, fluorescence intensity decreased when 
increase the peptide length units were co-expressed. LEA K 24aa (E) and LEA K 23aa 
(K) contain charged amino acids at C-terminus after 24hr incubation (Figure 2.10 b (f)), 
their fluorescence intensity decreased with an increase in cell growth and as a comparison 
to control without LEA peptide pRSF Duet GFP vector the expression of GFP very low. 
The GFP fluorescence intensity was stable with the substitution of amino acids with 
increase the length of LEA K peptide length. 
The GFP expression effectively decreases with decrease the length of LEA peptide. 
LEA K (9) and LEA K (5) show less expression of GFP with increase the culture time 
(Figure 2.12 (a-f)). The cell growth of short peptide containing in transformant is 
increased with increase the culture time (Figure 2.10). 
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Figure 2.7 Co-expression of each long LEA peptide in Escherichia coli. Time 
dependence of cell growth with the co-expression of each mutated LEA peptide after 
IPTG induction. Data are mean values ±SE, with 5 independent repeats. 
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Figure 2.8 Time dependence of target protein (GFP) expression with the co-
expression of each long LEA peptide after IPTG induction. The x axes the culture 
time (hr) after induction IPTG and y axes represent LEA peptide expression. 
Analysed with without LEA peptide expression in GFP. Data are mean values ±SE, 
with 5 independent repeats. 
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Figure 2.9 Co-expression of each short LEA peptide in Escherichia coli. Time 
dependence of cell growth with the co-expression of each mutated LEA peptide after 
IPTG induction. Data are mean values ±SE, with 5 independent repeats 
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Figure 2.10 Time dependence of target protein (GFP) expression with the co-
expression of each short LEA peptide after IPTG induction. The x axes the culture 
time (hr) after induction IPTG and y axes represent LEA peptide expression. 
Analysed with without LEA peptide expression in GFP. Data are mean values ±SE, 
with 5 independent repeats. 
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2.3.5 Construction, characterization, and function of C-terminus change at 23rd 
position in the LEA peptides 
To elucidate the roles of C-terminus amino acid in the LEA peptides, the mutation was 
introduced into lysine (K) at the 23rd position with positive, negative, hydrophobic amino 
acids (Table 2.5). The corresponding LEA peptides were therefore characterized by 
negatively charged, positively charged, hydrophobic, and hydrophilic amino acids, 
respectively. The LEA peptide encodes a protein of 23 amino acids with a predicted 
molecular mass of 2617.10–2732.23 kDa and a pI of 9.10–9.70 (Table 2.16). The size 
and structure of the amino acids at C-terminus in the constructed LEA peptide might play 
an important role in peptide functions. 
 
Table 2.16 ExPASY value of C-terminus at 23rd position in the LEA peptides 
 
S.No 
LEA 
peptide 
ExPasy value 
M.W. GRAVY pI value 
+ve 
charged 
-ve 
charged 
1 LEA I 1379.5 -1.669 4.78 3 4 
2 LEA K (23) 2674.20 -1.883 9.63 10 6 
3 LEA K(A) 2617.10 -1.635 9.46 9 6 
4 LEA K (D) 2661.11 -1.865 9.10 9 7 
5 LEA K (E) 2675.14 -1.865 9.10 9 7 
6 LEA K (G) 2603.07 -1.730 9.46 9 6 
7 LEA K (L) 2659.18 -1.548 9.46 9 6 
8 LEA K (N) 2660.12 -1.865 9.46 9 6 
9 LEA K (Q) 2674.15 -1.865 9.46 9 6 
10 LEA K (R) 2702.21 -1.909 9.70 10 6 
11 LEA K (S) 2633.10 -1.748 9.46 9 6 
12 LEA K (V) 2645.15 -1.530 9.46 9 6 
13 LEA K (W) 2732.23 -1.752 9.46 9 6 
 
The annotation and description according to the ExPASy. The peptides in the first column 
are used throughout the paper as a shortcut. MW (Da) (Molecular Weight) in Dalton of 
LEA peptides based on amino acids sequence. GRAVY (grand average of hydropathy) 
quantitates the hydrophilicity of the LEA peptides based on amino acid sequence. pI value 
isoelectric point of the LEA peptides based on amino acid composition. 
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2.3.6 Co-expression of the C-terminus amino acid change at a 23rd position in LEA 
peptide to co-express the target protein 
The expression of GFP as a target protein for cellular expression to investigate the 
function of co-expressed LEA peptides in the cell because the evaluation of its expression 
(fluorescence) is very simple to detect without extraction from the cell. 
The growth curves of E. coli cells in each change C-terminus is same (Figure 2.11). 
Cells with all the LEA peptide types grew well under the same conditions after IPTG 
induction, as observed at every 4h of incubation at 37°C (Figure 2.12). In contrast, 
fluorescence intensity increases after changing the C-terminus position of long Change 
LEA peptide. LEA K (A) shows highest fluorescence intensity as a comparison to other 
change C-terminus change amino acid at a 23rd position. As a comparison to control the 
fluorescence intensity increase when peptides of greater lengths were co-expressed.  
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Figure 2.11 Co-expression of each C-terminus change amino acid at a 23rd position 
in LEA peptide in Escherichia coli. Time dependence of cell growth with the co-
expression of each mutated LEA peptide after IPTG induction. Data are mean 
values ±SE, with 5 independent repeats. 
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Figure 2.12 Time dependence of target protein (GFP) expression with the co-
expression of each mutated LEA peptide after IPTG induction. The x axes the 
culture time (hr) after induction IPTG and y axes represent LEA peptide expression. 
Analysed with without LEA peptide expression in GFP. Data are mean values ±SE, 
with 5 independent repeats. 
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2.4 Discussion 
 
  LEA proteins have been found widely distributed in the plant kingdom, from algae, 
moss, ferns, to angiosperms (Battaglia and Covarrubias, 2013; Close, 1997; Cuming, 
1999; Hong-Bo et al., 2005; Hundertmark and Hincha, 2008). Interestingly, LEA proteins 
also accumulate in anhydrobiosis invertebrates and some bacterial species in response to 
water limitation. The sequences of these amino acids are heterogeneous(Dure et al., 1989; 
Tunnacliffe and Wise, 2007). GFP expression in E. coli as a target protein suggested 
differences in the intracellular localization and possibly in the targets with a specific 
function cellular compartments.  
LEA proteins are involved in the protection and stabilization of cellular structures by 
ion sequestration and stabilization of macromolecules such as membrane proteins (Hand 
et al., 2011; Hoekstra et al., 2001; Wolkers et al., 2001). LEA peptides with a higher 
number of positive and negative amino acid residues have been demonstrated to show a 
higher fluorescence intensity than LEA peptides with fewer such residues. The polar 
residue of amino in the LEA peptide plays an important role in interacting with the target 
protein and stabilization. In the group 3 LEA proteins model based LEA peptide 11-mer 
repeating motifs of playing a role as molecular shields for desiccated proteins, regardless 
of their structures in water (Dure et al., 1989; Kikawada et al., 2006; Madin and Crowe, 
1975; Tunnacliffe and Wise, 2007). Furthermore, LEA peptides with a high content of 
positively and negatively charged residues showed increased fluorescence intensity.  
Therefore, LEA peptides, also G3LEA protein repetitive units of the 11-mer motif. The 
amino acid composition other than its 11-mer motifs shares their characteristics, i.e., it is 
also abundant in charged residues, especially glutamic acid and lysine. Both glutamic acid 
and lysine increase the GFP fluorescence intensity in the BL21 (DE3).  In the previous 
study, to analyze the peptide function of co-expressed LEA peptide inside the cell, various 
types of LEA peptides were designed and constructed by the amino acid sequence of the 
G3LEA protein(Ikeno and Haruyama, 2013).  
The mutated LEA peptide of charged amino acid less is drastically decreased in the 
function. The serine-containing LEA peptide showed less GFP intensity in E. coli as 
compared to a LEA-I peptide. I can reasonably speculate that amino acids with an 
electrostatic charge might protect and stabilize the structure of macromolecules of 
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membranes such as proteins. On the other hand, GFP co-expression is relatively low in 
LEA peptides LEA-I and LEA-S 13aa. The sequences of the amino acid of these peptides 
are LEA-II 13aa contains a hydrophobic amino acid (L-Lucien; L) in the 5th position of 
the original LEA-I 13aa. In the LEA-III and LEA-IV, basic and acidic amino acid 
residues, respectively, were replaced by glycine (G) residues. Some functional amino 
acids in LEA-I peptide sequence were changed to Glycine except at 6th and 12th position 
of Glycine. In LEA-V, hydrophobic alanine (A) residues in the sequence were replaced 
by a hydrophilic amino acid (L-serine; S) (Ikeno and Haruyama, 2013). Mutated LEA 
peptide 13aa LEA-S less GFP expression as the comparison to another mutated LEA 
peptide, 13aa the time course of GFP expression after induction when each of the LEA 
peptides was co-expressed. The protein expression increased slightly when LEA-II 13aa 
but LEA-II 12aa are less was co-expressed compared with co-expression with LEA-I 
13aa. In contrast, the expression of GFP was notably reduced when peptides with fewer 
charged amino acids were co-expressed.  For the boost protein expression by co-
expression of LEA peptides positively and negatively charged amino acids in the peptide 
sequence are essential. The expression of all mutated 12aa without 2nd D (Aspartic acid) 
are low fluorescence intensity as compare to 13aa mutated LEA peptide and previously 
constructed LEA-I 13aa and LEA-II 13aa(Ikeno and Haruyama, 2013). The role of 2nd 
position D (Aspartic acid) amino acid very important for this co-expression. 
To achieve the functional role of LEA peptide length in the co-expression system, the 
length of LEA peptide was increased one by one and also decreases the length of the 
length of LEA peptide sequence. In previously, the repetitive unit of LEA peptide 
(AKDGTKEKAGE) were used the expression of GFP decrease(Ikeno and Haruyama, 
2013). The length of LEA peptide reached up to 23 amino acid and 24 amino acid the 
expression of GFP, fluorescence intensity was decreased. To evaluate the role of C-
terminus in the LEA peptide length, the 23rd amino acid LEA K (23) was changed with 
charged, hydrophobic, basic and acidic amino acid. The current study confers the C-
terminus amino acid as crucial for the construction of LEA peptide sequence. In contrast, 
the present elevation of protein expression by using a LEA peptide is highly versatile. 
From the above results, I hypothesize that hydrophobic residues of LEA peptide attach to 
the protein surface and that the charged residues inhibit protein aggregation within the 
cell by mean of their electrostatics charges. 
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I conclude that repeating units of hydrophobic, charged amino acids are essential for 
the function of LEA peptides. C-terminus amino acid at the long chain LEA peptide also 
crucial to stabilizing the target protein co-expression. Moreover, specific point mutations 
are beneficial for the enhancement of LEA peptide function. Such LEA peptides might 
help to co-express the target protein in the cell. In contrast, the present elevation of protein 
expression by using a LEA peptide is highly versatile. This method is simple, in that the 
protein is co-expressed with only an 11-amino acid peptide. Also, the separation process 
for protein purification is straightforward, because the co-expressed peptide is minimal. 
These results indicated that the size and nature of amino acids in LEA peptides are 
significant to stabilize and express the target protein. However, these results are 
preliminary, and a wide range of evidence is warranted to support this hypothesis. In 
future studies, I hope to re-design novel LEA peptides to produce recombinant proteins 
by using more efficient protein co-expression system and elucidate the mechanism of this 
policy by analysis of the LEA peptide expression and function in transformant cell. 
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Chapter 3: Control the expression of LEA peptide and 
recombinant protein through dual expression system. 
 
3.1 Introduction 
  In the past, empirically heterologous gene expression was often used, and many types 
of transformant had to test (Terpe, 2006; Zhou et al., 2006). Testing requires not only 
sub-cloning into several expression vectors including different epitope tags or fusion 
proteins, but subsequent analysis under natural conditions successful gene expression 
(Mumberg et al., 1995; Pijlman et al., 2006; Shivprasad et al., 1999). The choice of the 
transformant is therefore essential since it also determines the quantity and quality of the 
recombinant biologically active proteins (Hopp et al., 1988; Vera et al., 2007). Taking 
this into account, protein expression in both prokaryotic and eukaryotic systems 
expression vector that would allow significantly involved to the reduced workload, time 
and costs (Sørensen, 2010).  
Three-dimensional structures provide a wealth of information regarding the mechanism 
of action constituent proteins, protein complexity (Rousseau and Schymkowitz, 2005; 
Yeaman and Yount, 2003). The protein structures may be obtained pure, individually 
purified proteins and mixed (Johnson et al., 1999; Safarik and Safarikova, 2004). 
However, the expression binding-partner protein for folding and stability are required for 
some proteins (Jermutus et al., 2001; Sørensen and Mortensen, 2005a, b). Two methods 
commonly used: the bicistronic vector and the dual-vector systems for heterologous co-
expression of partner proteins. The two systems are different, for the same protein to be 
produced in both bicistronic vector and the dual-vector systems; multiple expression 
plasmids are typically used since the elements needed for efficient replication, selection, 
mRNA transcription, and protein translation (Finkelstein et al., 2003; Kim et al., 2004; 
Kirsch et al., 2005; Rucker et al., 1997). Additionally, the construction and verification 
of plasmids must be shuttled between different host strains for the cloning and expression 
steps of these multiple plasmids are time-consuming, laborious, and error-prone. 
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Within the past decade, Many useful simple and convenient overexpression systems 
methods have been developed for the expression of recombinant protein, but the 
commonly used system for the protein expression are bacterial expression system(Drew 
et al., 2006; Terpe, 2006; Wagner et al., 2008). The mechanisms and the composition of 
protein in vivo and in vitro studies have demonstrated the importance of reunion of 
protein molecules to resolve the complexity of biological processes (Bilheimer et al., 
1972). Active protein is present as heteromeric complexes, due to scientific interest and 
enhance the production rate of the bioactive peptide by using recombinant technology 
(Lodish et al., 1995; Prusiner et al., 1998; Tribe, 1976). The construction of heteromeric 
molecules of proteins relies on the ability to redesign such heteromeric protein structures 
from individually prepared and designed recombinant proteins, a process that often 
involves improving the surface, complexity, refolding and binding property of the protein 
(Prusiner et al., 1998; Tribe, 1976). These heteromeric complexes key regulators can 
differ in size, varying from only two or three-components to large multimeric-complexes 
in many cellular processes. Sometimes express many proteins in one plasmid is not ideal 
and in cases its impossible to stabilize the where one protein is unstable without the other 
the protein molecules (Macrina et al., 1978).  
The expression of recombinant proteins in E. coli cell is influenced by the many factors, 
including the transformant and cell lines used for the expression, minimal medium, the 
expression system, temperature,  time of induction, quantity of inducer  (Busso et al., 
2011; Sawitzke et al., 2007). In addition to the factors, the results of protein co-expression 
are affected by several specific elements to enhance or decline the production rate of 
protein and also quality & quantity (Baneyx, 1999; Cereghino and Cregg, 2000; 
Ghaemmaghami et al., 2003). Co-expression of recombinant protein can be conducted 
using either single or multiple plasmids. In the case of an individual vector, this can be 
either by using poly-cistronic co-expression system, by targeting single promoter of 
various genes or by using separate promoter for every single gene (Busso et al., 2011; 
Celie et al., 2016; Farrokhi et al., 2009). For harbour, the compatible or incompatible (i.e., 
similar) replicons, in the plasmid by using a different antibiotic selection marker and two 
or more constructs are co-transformed into a single cell (Busso et al., 2011; Cabello et al., 
1976; Sawitzke et al., 2007).  
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   To generate such a vector expression system, two commonly plasmids have to be 
chosen for the expression of recombinant, for heterologous recombinant proteins 
production, in the E. coli. Early successes in the production of heterologous proteins were 
achieved using the well-studied bacterium E. coli (Drew et al., 2006; Terpe, 2006). This 
prokaryotic expression system is easy to handle and a cost-effective and cost-worthy and 
also high production rate of heterologous recombinant proteins. However, the expression 
of a various type of proteins, mainly eukaryotic gene expression, often leads to the 
creation of denatured and aggregated protein, localized in inclusion bodies and only a 
small fraction matures into the desired native form. In the previous study, Ikeno et al., 
2013 were designed LEA peptide based on G3LEA protein of P. vanderplanki and 
targeted the GFP, CAT and GUS protein. The expression of target protein enhances 
through previously constructed LEA peptide co-expression system (Ikeno and Haruyama, 
2013). LEA proteins were first identified as abundant proteins in the late stages of embryo 
development. The repeating 11-amino acid it’s the characteristic property of Group 3 
LEA protein sequence that is observed in diverse organisms such as nematode, and 
eubacteria (Dure et al., 1989; Gal et al., 2004; Madin and Crowe, 1975). The motif 
characterized by hydrophobic residues at position 1, 5 and 9; negatively charged residues 
at positions 3, 7 and 11; and positively charged residues at positions 2, 6 and 8 in PvLEA1, 
PvLEA2, and PvLEA3 (Kikawada et al., 2006). A random assortment of amino acids are 
found in the other position (4 and 10), and these are not involved in the function of the 
LEA protein. The outstanding features of the 11-mer motif of G3LEA proteins are its 
high hydrophilicity and high glycine, glutamic acid, lysine, and threonine content at the 
C-terminal portion (Furuki and Sakurai, 2016; Shimizu et al., 2010). The high content of 
glycine residues in most LEA proteins allows these proteins to exist in randomly coiled 
structures, but some variation occurs among the members of different families, with no 
significant sequence similarity (Close, 1997; Dure et al., 1989; Furuki et al., 2011; 
Hundertmark and Hincha, 2008; Kikawada et al., 2006; Tunnacliffe and Wise, 2007). 
   Here I focus on to most important strategies for recombinant protein production by 
constructing a novel Escherichia coli dual expression vector to produce recombinant 
proteins. In this expression system, an E. coli containing two plasmids pRSF Duet and 
pBAD one for LEA peptide expression and one for GFP, both plasmid has a selective 
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marker. In the previous chapter, the issues including expression system, selection of host 
and most crucial LEA peptide design strategy were addressed. Ikeno et al. 2013, focused 
on the expression of the target protein by co-expressing of LEA peptide through the same 
plasmid, but they can’t explain the role of LEA peptide and effect of LEA peptide on the 
target protein. The expression of target protein enhance when increasing the culture time 
of incubation but they fail to explain possibility of increase of the LEA peptide expression 
inside the cell. Through that in the present study, the expression of green fluorescence 
proteins in E. coli was compared using the single expression vector. For this purpose, two 
type of expression plasmid vectors were constructed. The mechanism elucidated it will 
be necessary to study the dependence on the LEA peptide sequence and timing of the 
induction of the expression of LEA peptide. Adaptability for various types of the 
expressed protein system, and the protein folding with this LEA peptide in vitro of this 
phenomenon. In this study, the control expression of a target protein and the expression 
timing was investigated. Through that dual expression system, the control expression of 
recombinant protein is enabled in future. In this chapter, the influence of expression 
control of LEA peptide on the expression of the target protein was investigated by 
constructing the novel dual-expression system and evaluating the expression of the target 
protein (GFP) against the change in expression induction of the LEA peptide. The 
expression can be controlled individually by the addition amount of the expression 
inducer. 
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3.2 Materials and methods 
 
3.2.1 Plasmid construction for E. coli transformation 
pRSF Duet-1 plasmid (3829 bp) (Novagen Merck KGaA, Darmstadt, Germany) and 
pBAD/Myc-His plasmid (Invitrogen) was used as an expression vector for the co-
expression of LEA peptide and GFP. pRSF Duet-1 contains two multiple cloning sites, 
namely, MCS1 and MCS2, together with ribosome-binding sites and an IPTG inducible 
T7 lac promoter vector. At the cloning site of MCS2, LEA was subcloned into the XhoI 
and EcoRV site of the pRSF Duet-1 vector. pBAD/Myc-His contains one cloning sites, 
GFP gene was subcloned into the XhoI and HindIII site of pBAD MCS. Arabinose 
inducible araBAD promoter PBAD / Myc-His (4094 bp) (Invitrogen) vector with araBAD 
promoter was used for expression of GFP which is a target protein (Figure 3.1). The GFP 
gene was amplified through PCR from previously constructed pRSF Duet-1 GFP-LEA-I 
vector. The construction of the expression vector was verified by DNA sequencing using 
FASMAC (Atsugi, Japan). All the oligo-DNAs were obtained from GeneNet (Fukuoka, 
Japan).  
To diminish or knockout incompatibility between pRSF Duet-1 and pBAD/Myc-His 
plasmids by choosing plasmids of the same group for their capacity to coexist and both 
plasmids have different selectable markers, e.g. one with kanamycin resistance and one 
with ampicillin resistance gene. 
 
 
Figure 3.1 pRSF Duet-1 plasmid and pBAD/Myc-His plasmid 
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3.2.2 Strains and culture conditions  
The vectors pBAD-GFP and pRSFDuet-LEA1 constituting the novel LEA peptide co-
expression system constructed in E. coli strains Nova Blue and BL21(DE3) were used for 
the construction of plasmids and the expression of recombinant protein. All cloning was 
performed using E. coli strains grown at 37°C in Luria–Bertani (LB) liquid media 
supplemented with 50 μg/ml kanamycin and 100 μg/ml ampicillin on plates solidified 
with 1.5% agar. 
 
3.2.3 LEA peptide and GFP dual expression system 
  For the dual expression system competent cells were transformed through heat shock, 
after that, the plate was incubated at 37 ° C. for 10 hours. A single colony was collected 
with a toothpick and inoculated into 3 ml of LB (Km +, Amp +) medium. Cultivation was 
carried out at 37 ° C. and 160 rpm lateral shaking (12 to 14 hours). 2 ml of the culture 
solution was collected and inoculated into a 500 ml Erlenmeyer flask containing 200 ml 
of prepared LB (Km +, Amp +) medium. The culture was rotated and shaken at 37 ° C. 
at 160 rpm, and the culture was cultured until O.D. 600 nm = 0.45-0.5. In to the 20 
sterilized test tubes transfer the 6 ml of the culture solution and the expression inducer. 
30 μl (final concentration 0.1%), 60 μl (final concentration 0.2%), 120 μl (final 
concentration 0.4%), 240 μl (final concentration 0.8 %) In each case. To each test tube of 
arabinose concentration, 0 μl, 0.6 μl (final concentration 0.01 mM), 6 μl (final 
concentration 0.1 mM), 30 μl (final concentration 0.5 mM), and 60 μl (final concentration 
1 mM) of 0.1 M IPTG was added. 200 μl cultures were transferred in to the 96 well plate. 
This plate was incubated at 37 ° C and 1000 rpm with shaking. After that, the O.D. 600 
nm and the fluorescence intensity were measured at 0, 4, 8, 16 and 24 hours using a 
microplate reader. 
 
3.2.4 Time independent co-expression of GFP and LEA peptide in E. coli through 
dual expression system  
In this experiment, examine the influence on the GFP expression by the expression 
timing of the LEA peptide. The 50 μl of IPTG (final concentration of 0.1 mM) was added 
to induce expression of LEA peptide. GFP expression was induced by adding 500 μl (final 
concentration: 0.2%) of 20% L-arabinose. The initiation of induction of GFP expression 
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was set to be 2 hours and 40 minutes after the start of cultivation in a 500 ml Erlenmeyer 
flask, and the start time of LEA peptide expression induction was 2 hours before, 1 hour 
before, simultaneously with the GFP expression induction time 1 hour, 2 hours.  
Samples were taken at 0, 2, 4, 6, 8 and 24 hours after the initiation of GFP expression 
induction, and the fluorescence intensity was measured at OD 600 nm. 
Measurement of the fluorescence intensity was carried out using a sample obtained by 
suspending the sample with 0.1 M phosphate buffer so that O.D. 600 nm = 0.2. 3 ml of 
the sample suspended in the phosphate buffer was collected and placed in a tetrahedral 
cell, and O.D. 600 nm and fluorescence intensity were measured (Figure 3.2).  
 
 
 
Figure 3.2 Co-expression of GFP and LEA peptide in E. coli through dual expression 
system; a) initiation of induction of GFP expression and b) dual expression system, 
plasmid and competent cells  
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3.2.5 Constitutive co-expression of LEA peptide and GFP by dual expression system 
in E. coli 
 The plasmids were transformed in the E. coli strains BL21(DE3) for the co-expression 
of LEA peptide, and target proteins were cultured in LB liquid medium supplemented 
with 50 μg/ml of kanamycin and ampicillin at 37°C about 12 h. The bacterial cultures 
were diluted 100-fold using fresh liquid LB medium and allowed to incubate for 2–3 h at 
37°C until the exponential growth phase (OD600 = 0.5). Isopropyl-thio-β-D-
galactopyranoside (IPTG) was added into the cell cultures at a final concentration of 0.1 
mM and Arabinose (Arb) was added into the cell cultures final concentration 0.2% to 
induce the expression of the inserted gene in recombinants, and further grown at 37°C for 
24 h. One milliliter of the growing microorganism was collected by centrifugation at 1500 
×g for 10 min and suspended with 0.1 M phosphate buffer (pH 7.4). Cell growth was 
detected at an optical density of 600 nm, and GFP fluorescence of E. coli was measured 
at 0, 4, 8, 12, 16, 20 and 24 h by fluorescence spectrometry on an FP-6600 instrument 
(Jasco, Tokyo) at an excitation of 488 nm and emission of 508 nm 
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3.3 Results 
 
3.3.1 Effect of LEA peptide expression on GFP expression 
To evaluate the effect of the expression level of LEA peptide on GFP expression, IPTA 
was added in a concentration range from 0 mM to 1 mM final concentration to express 
LEA peptide, and it was investigated how the expression level of GFP was affected It 
was. Expression of GFP was also performed by addition of arabinose. Arabinose was 
added in a concentration range from the final concentration of 0.1% to 0.8%. The culture 
was performed for 24 hours, and the fluorescence intensity and the turbidity were 
measured at 0, 4, 8, 16 and 24 hours. The fluorescence intensity of GFP is shown in 
(Figure 3.3) for each measurement time. 
The expression level of GFP was increased with culture time. However, GFP expression 
levels at 16 hours and 24 hours were comparable for those not co-expressed with LEA 
peptide. Also, the expression level of GFP at the time of culturing for 24 hours were 
increased with an increase in the amount of arabinose addition, but the same expression 
level was obtained at both 0.4% arabinose addtion and 0.8% addition. 
Expression induction of LEA peptide at 0.01 mM IPTG and co-expression with GFP 
was slightly increased its expression level compared to GFP alone expression. 
Furthermore, when the expression level of LEA peptide was increased, the GFP 
expression level increased markedly. The highest effect was obtained when IPTG was 
added at 0.1 mM, and the expression level of GFP was the maximum when arabinose was 
added from 0.2% to 0.8%. Among them, when arabinose was added at 0.8% and IPTG at 
0.1 mM, the maximum expression of GFP was observed as a whole, and the expression 
level was about 10 times higher than when GFP alone was expressed. However, when 
IPTG is added at 0.5 mM or more, the expression level of GFP was lower than when the 
addition amount of 0.1 mM was added.  
  
85 
 
 
 
 
 
 
Figure 3.3 Evaluate the effect of the expression level of LEA peptide on GFP 
expression; A) 4hr, B) 8hr, C) 16hr, and D) 24hr Arabinose was added in a 
concentration range from the final concentration of 0.1% to 0.8%. The culture was 
performed for 24 hours, and the fluorescence intensity and the turbidity were 
measured  
 
  
 
  
86 
 
3.3.2 Investigation of the influence on GFP expression by regulation at induction of 
LEA peptide expression 
 The effect is inducing time of GFP expression changes when the initiation time of 
induction of LEA peptide is changed before and after induction of GFP expression. 
Expression of LEA peptide was induced 2 hours, -1 hour, simultaneous, 1 hour, and 2 
hours after induction of GFP expression. Turbidity and expression level of GFP was 
measured every 2 hours up to 8 hours and 24 hours. Cell growth curve is shown in Figure 
3.3.2a and GFP expression level is shown in Figure 3.3.2b. Here, the control shows that 
GFP alone is expressed without co-expressing the LEA peptide. 
Since the amount of IPTG added is the same, it is considered that there is no big 
difference in the expression level of the LEA peptide, but there is a large difference in the 
expression amount of GFP between the respective samples. There was no significant 
difference in the expression level of GFP among the samples in which the LEA peptide 
was expressed after induction of GFP expression. However, when the LEA peptide was 
expressed before induction of GFP expression, the expression level of GFP remarkably 
increased. When compared with the control, the expression level was about 6 times. 
There was also a difference in cell proliferation. It is well known that cell proliferation 
is suppressed when IPTG is added. Therefore, when IPTG is added and expression 
induction of LEA peptide is started, cell proliferation is suppressed at that time. However, 
when expression of LEA peptide was induced from before the initiation of induction of 
GFP expression, the number of cells increased after measurement 6 hours after induction 
of GFP expression. 
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Figure 3.4 Effect the time on co-expression system; a) cell growth and b) 
fluorescence intensity 
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3.3.3 Effect of constitutive co-expression of LEA peptide and GFP dual expression 
system E. coli 
To evaluate the effect of the expression level of LEA peptide on GFP expression, IPTG 
was added in a concentration 0.1 mM final concentration to express LEA peptide, and it 
was investigated how the expression level of GFP was affected. Expression of GFP was 
also performed by addition of arabinose. Arabinose was added in a concentration as the 
final concentration of 0.2%. The culture was performed for 24 hours, and the fluorescence 
intensity and the turbidity were measured at 0, 4, 8, 16, 20 and 24 hours. The fluorescence 
intensity of GFP is shown in (Figure 3.3.3) for each measurement time. LEA peptide was 
expressed the expression level of GFP remarkably increased. When compared with the 
control, the expression level was about 3 times at 24 hours. 
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Figure 3.5 Evaluate the effect of the expression level of LEA peptide on GFP 
expression; A) Cell growth and B) Fluorescence arabinose was added in 
concentration 0.2% and IPTG was added in 0.1mM. The culture was performed for 
24 hours, and the fluorescence intensity and the turbidity were measured. The x axes 
the culture time (hr) after induction IPTG and y axes represent LEA peptide 
expression. Analysed with without LEA peptide expression in GFP. Data are mean 
values ±SE, with 4 independent repeats. 
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3.4 Discussion 
In this study, the effect of two different plasmid co-expression systems on the production 
of GFP by co-expressed of LEA peptide in E. coli was examined. The selection of vectors 
used for expression strategies that are common and simple to handle with plasmid 
incompatability (Feinbaum, 2001; Prather et al., 2003; Selleck and Tan, 2008). These two 
plasmids are beneficial for the high-throughput production of recombinant protein, 
cloning of the gene, the screening for suitable restriction sites and easy to transformant in 
the cells. Indeed, many molecular biologists and structural genomics centers have 
successfully used and applied these two plasmids for high-throughput protein production 
in the E.coli (Rosano and Ceccarelli, 2014; Sørensen and Mortensen, 2005a). For most 
plasmids optimized codon of the insertion gene, an N-terminal tag, RBS sequence and 
optimized promoter (Arnau et al., 2006; Burgess-Brown et al., 2008; Rosano and 
Ceccarelli, 2014; Wu et al., 2004). However, for protein expression, expression of non-
tagged proteins at mRNA levels influences translations, protein expression, and complex 
formation in the cell or after purification of proteins (Busso et al., 2011). 
So far, the sequence of the LEA peptide was modified to enhance the heterologous 
protein expression-promoting the effect of the LEA peptide, and have designed a more 
functional LEA peptide. However, it was difficult to control the expression level of only 
the LEA peptide in the co-expression system of the LEA peptide and target protein used 
in previous studies. Genes such as LEA peptide and target protein are introduced 
downstream of the two T7 promoters in this expression vector, and the expression thereof 
is controlled. Therefore, when inducing expression by IPTG, the LEA peptide and the 
target protein are simultaneously expressed, so that there is a problem that the expression 
level of each cannot be controlled. Therefore, the influence of expression level of LEA 
peptide on target protein expression has not been clarified. 
Comparing the results obtained the IPTG and Arabinose concentration effects the 
protein production. The low to the high amount of inducer concentration 0.01mM IPTG 
to 1mM IPTG and 0.1% to 0.8% Arb concentration for the five complexes, different co-
expression profiles can be observed (Figure 3.3). Production of  GFP shows high 
fluorescence intensity pattern; either the complex is virtually 0.1mM IPTG and 0.8% Arb. 
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This results can be explained by the observation that expression of GFP relies on the 
expression of LEA peptide. The GFP is expressed in decent amounts with relatively small 
without expressing the LEA peptide. At a different concentration of inducer in expression 
levels between two vector systems inhibit and low the Fluorescence intetensity at 1mM 
IPTG and 0.8% Arb were little low and 0.0mM IPTG and 0.8% Arb (Figure 3.3).  
The expression profile of the before expressing LEA peptide also was shown the impact 
on the  GFP. Significant variation at the time of each vector allows expressing 
individually inducing between the different plasmid to achieve co-expression systems. 
Lots of challenges that may arise, during the expression and production of each plasmid 
and protein, an inducer rate, and two components expression in the same transformant. 
From the results obtained, there is no particular strategy for the two different plasmids 
that stands out from the others. A valid comparison between the dual-expression and 
single expression system with either incompatible (chapter1) or compatible (chapter3) 
cannot justify due to the limited number of protocol and experimental methodology 
performed. In previously, the expression of each target protein enhances with a time of 
incubation at 13mer LEA peptide co-expression system. The role of functional amino 
acid for designing the LEA peptide co-expression are also important(Ikeno and 
Haruyama, 2013). The number of amino acid in LEA peptide sequence effectively control 
the target protein expression. In this study the majority are based on the inducer 
concentration and the time of expression dominate the profiles for dual expression 
systems. Dual expression systems produce a quite high amount of recombinant protein, 
still I focused on the new strategy for all the enhancement of protein expression in the 
E.coli.  According to my hypothesis, this LEA peptide acts a molecular shield to enhance 
the target protein expression. The LEA peptide expressing before enhance the expression 
rate of the target peptide. The compatibility and comparison between co-expression from 
dual expression per plasmid constructs, comprising either one promoter per plasmids or 
one promoter per gene significantly understudy, in particular for expression. Together 
with this results indicate that different co-expression vectors and strategies can 
successfully apply for production of recombinant protein complexes in high yields. This 
results, shows that the LEA peptide acts intracellularly and improves the expression of 
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GFP. The mechanism of LEA peptide to enhance the target protein co-expression are 
under study.  
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Chapter 4: The function of LEA peptide against abiotic 
stress in E.coli 
 
4.1 Introduction 
 
Abounding divergent form of secreted bioactive peptides can play an aspectes as 
regulators of cell-to-cell communication, cell signalling, defence mechansim in 
plants(Korhonen and Pihlanto, 2006; Möller et al., 2008). Bioactive peptides are derived 
from large inactive proteins molecules with an N-terminal signal sequence directing the 
protein to the secretory pathway for the signalling. Small biosignaling active peptides are 
principally classified into, the (PTM) post-translationally modified peptides and the 
(CRPs) cysteine-rich peptides. Peptides altered by modifications such as tyrosine 
sulfation, proline hydroxylation and hydroxyproline glycosylation and typically 
substituted with 20 amino acids(Kitts and Weiler, 2003; Silverstein et al., 2007). CRPs 
play a vital a vital role in plant physiology and metabolism and has a characteristic 2 to 
16 number and linear arrangement of cysteine residues of amino acids(Dimarcq et al., 
1998; Silverstein et al., 2007). The biologically active mature peptides obtained by 
additional processing on the precursor proteins. AMPs (antimicrobial peptides) that 
display a wide range of antimicrobial activity against bacteria, fungi and viruses. The 
smallest known AMP low molecular weight peptides made of 7 amino acids (lys-val-phe-
leu-gly-leu-lys) of a fewer to more than 100 amino acids(Park and Hahm, 2005; Reddy 
et al., 2004; Tomàs Pérez and Boix Borrás, 2015).  
The group of highly hydrophilic proteins accumulates under abiotic stresses(Battaglia 
et al., 2008; Wang et al., 2003). The 11aa peptide cysteine-rich secretory proteins from 
c-terminus, antigen 5, and pathogenesis-related 1 proteins (CAP) superfamily plant 
peptides involved in high salinity resistance(Chien et al., 2015). In Arabidopsis CAPEs 
CAP-derived peptides that are involved in salt responses(Chien et al., 2015). The gene 
isolated from S.europea, SeNHX1 (vacuolar Na+/H+ antiporter), SeCMO (glycine betaine 
biosynthesis), SePSY (carotenoid biosynthesis), and SeLCY (carotenoid biosynthesis) 
was intracts and confers salt tolerance. The expression S. europaea salt tolerance gene 
also improves salt tolerance in transgenic plants(Han et al., 2008; Jha et al., 2011). LEA 
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proteins hydrophilic proteins associated with the development of seeds and pollen grains, 
or some stages of the shoot and root development(Hong-Bo et al., 2005).  Some LEA 
proteins have also been found associated with vascular tissues and in meristematic 
regions(Battaglia et al., 2008; Dure et al., 1989). An extensive set of protein-coding genes 
can be transcriptionally activated to develop a stress response(Åkerfelt et al., 2010; 
Harding et al., 2000). However, there is still no detailed information on the influence of 
the expression of small biomolecules such as peptides in vivo for generating a suitable 
reaction against abiotic stresses(Bartwal et al., 2013).  LEA protein expression confers 
tolerance in response to salt, temperature, drought, and osmosis as well as some signaling 
molecules, in many plant species, invertebrates, and higher and lower microorganisms 
(Battaglia et al., 2008; Furuki et al., 2012; Furuki et al., 2011; Gal et al., 2004; Goyal et 
al., 2005b; Grelet et al., 2005; Hatanaka et al., 2015; Kikawada et al., 2006; Liu et al., 
2013; Shimizu et al., 2010; Wolkers et al., 2001). The aquatic larvae of Polypedilum 
vanderplanki survive under drought in an almost entirely dehydrated state during the dry 
season in a semi-arid area. This phenomenon, termed "anhydrobiosis," has been attributed 
to expression of its LEA proteins(Browne et al., 2002; Madin and Crowe, 1975). 
LEA proteins showed a potential role in stress tolerance. By in vitro experiments, their 
function in protein protection upon water deficit(Hand et al., 2011). LEA proteins were 
demonstrated as hydrophilins, including from groups 2, 3, and 4, could prevent enzymes 
inactivation such as LDH (lactate dehydrogenase) or MDH (malate dehydrogenase) upon 
different water deficits conditions. Similarly, protective properties were also detected 
during freeze-thaw in vitro assays (Battaglia and Covarrubias, 2013; Hand et al., 2011; 
Madin and Crowe, 1975).  Goyal et al., 2005b; Chakrabortee et al., 2007; in vitro 
desiccation tolerance assays by using the high ration of LEA: target proteins, suggested 
that some LEA and LEA-like proteins can avoid protein aggregation.  Besides, some 
reports indicate LEA proteins were enhance protecting effect under dehydration in the 
presence of trehalose.  Group 3 LEA proteins have a distinct number of repetitions of the 
11-mer motif or repeated amino acids configured as an amphipathic alpha-helix 
(TAQAAKEKAGE), which determines the molecular mass of this group (Dure et al., 
1989; Gal et al., 2004; Tunnacliffe and Wise, 2007). Several LEA proteins and dehydrins 
have been discovered in plants and animals to date, which acts as molecular chaperones 
to protect the membrane proteins, cell organelles, the activity of enzymes, and nucleic 
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acids under various stress conditions(Close, 1997; Furuki et al., 2011; Hand et al., 2011; 
Kikawada et al., 2006). Although the specific mechanisms of protection are unclear, some 
LEA proteins have been shown to function as ion scavengers, molecular chaperones, or 
shields of macromolecules to avoid protein aggregation and restore improperly folded 
proteins under dehydration, heat, or freeze-thaw stresses(Close, 1996; Cuming, 1999; 
Goyal et al., 2005b; Wolkers et al., 2001).  
In the previous study, LEA peptide co-expression system was designed and constructed, 
which was used to target GFP and some other proteins for enhanced expression in E. coli 
BL21 (DE3). For the production of the recombinant protein in E. coli, LEA peptide 
sequences incorporated with the pRSF-Duet vector was designed, which were based on 
the 11-mer motif repetitive sequence of P. vanderplanki LEA (PvLEA) proteins. 
Expression of the target protein (GFP) in E. coli was enhanced relative to that of the 
control strain that did not express the LEA peptide. I hypothesized that these LEA 
peptides function after translation to act as a molecular shield for stabilizing and 
protecting the target protein from lysozyme activity (Ikeno and Haruyama, 2013). 
 The present study aimed to further explore the potential utility of LEA peptides as 
biological protectants during abiotic stress from a high salt concentration. The initial 
objective was to clone and overproduce a target protein using previous LEA peptide co-
expression system. Although the specific functions of LEA proteins remain unknown, 
they are assumed to play important roles in the establishment of environmental stress 
tolerance in many species, and could therefore serve as promising biological protectants 
under stressful abiotic and biotic conditions. Therefore, the next objective of this study 
was to determine whether the synthetically designed peptide could play a vital role in 
protecting E. coli under a high salt condition in vitro. The LEA peptide expression vector 
was constructed and transformed into E. coli BL21 (DE3), and its effects on bacterial cell 
resistance to stress was examined. These results can provide a new tool for enhancing 
stress tolerance in genetically modified organisms for various applications, and provide 
insight into the function of the LEA peptide 11-mer motif sequence and the general 
mechanism of the response to abiotic stress.  
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4.2 Materials and methods 
 
4.2.1 Peptide design and plasmid construction 
The 13-mer peptide MDAKDGTKEKAGE was used as a model of LEA proteins 
originating from P. vanderplanki based on repeats of the 11-mer consensus motif, 
characteristic of Group 3 LEA proteins. pRSF Duet-1 plasmid (3829 bp) (Novagen Merck 
KGaA, Darmstadt, Germany) was used as an expression vector for the co-expression of 
LEA peptide. pRSF Duet-1 contains 2 multiple cloning sites, namely, MCS1 and MCS2, 
together with ribosome-binding sites and an IPTG inducible T7 lac promoter vector. At 
the cloning site of MCS2, LEA was subcloned into the XhoI and EcoRV site of the pRSF 
Duet-1 vector. The construction of the expression vector was verified by DNA 
sequencing using FASMAC (Atsugi, Japan). All the oligo-DNAs were obtained from 
GeneNet (Fukuoka, Japan).  
 
4.2.2 Cell culture  
E. coli BL21 (DE3) cells carrying the recombinant pRSF-LEA I vector were grown at 
37°C in Luria–Bertani (LB) medium supplemented with 50 µg/ml kanamycin. For the 
expression induction, different concentrations of isopropylthio-D-galactoside (IPTG), 0.0 
mM, 0.01 mM, 0.1 mM, 0.5 mM, and 1.0 mM, were added to the cell cultures at an optical 
density reached up to 0.5 at 600 nm (OD600).  
 
4.2.3 Tolerance and growth capacity of E. coli under salt stress 
Cell cultures were grown as described above, and IPTG was added to mid-log phase 
cultures (OD600 = 0.5) at a final concentration of 0 mM, 0.01 mM, 0.1 mM 0.5 mM, and 
1.0 mM. After IPTG induction, the cultures were incubated at 37°C (120 rpm) for 4h. The 
bacterial suspensions (1 ml) were taken at 4hr, and diluted in ten-fold serial steps up to 
the 10−6 dilution stage. From each diluted suspension, 50 μl was spread on the LB agar 
plate; the OD600 values from each sample were checked to confirm equal concentrations. 
For salt treatment, after IPTG induction, 50 μl of each sample was spread onto the LB 
plates (while again controlling the OD600 for each sample) containing phosphate buffer 
or 3% NaCl, 5% NaCl, and 7% NaCl, respectively. After the plates were incubated for 1 
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to 2 days at 37 °C, the number of colony-forming units on each plate was recorded. The 
survival ratio was calculated using the following equation:  
Survival ratio = (mean colony number on the salt plate/mean colony number on the 
control LB plate) × 100%. 
 
4.2.4 Heat and cold shock tolerance 
Evaluation of cold and heat tolerance was performed based on the growth of transformed 
E. coli BL21 (DE3) cells with pRSF-LEA I plasmids with different concentrations of 
IPTG. The cell cultures were incubated in LB liquid medium with IPTG for 4 h. For the 
thermophylactic experiments, the induced product was transferred to 1ml aliquots heated 
at 48 °C for 30 min, and then 100 µl of the serial dilutions were plated onto LB plus 
kanamycin plates. Cold shock tolerance was evaluated by exposure to cell cultures at 4 
°C for 24 h. One millilitre of the induced cultures (OD600 = 0.9–1.0) was cooled at 4 °C 
for 24 h, and then 50 µl was transferred to the LB agar plate and cultivated at 37 °C. The 
cell growth experiment was repeated three times, with essentially the same results 
obtained.  
 
4.2.5 Cell viability assay 
  Cell viability was measured using a colorimetric assay on 96-well plates with WST 
reagent and dimethyl sulfoxide (Microbial viability assay kit-WST, Dojindo, Kumamoto, 
Japan). Each plate contained blanks, controls, and 5% and 7% salt LB broth with stressed 
recombinant E. coli harbouring the pRSF-Duet plasmid with or without 0.1 mM IPTG, 
with five replicates for each dilution series. Cells were added to the plates at 0.5 cells/ml 
and cultivated for 2 h. After 4 h, 20 µl of WST (diluted 1:4 with phosphate buffer) was 
added and 180 µl cells were incubated for an additional 4 h. The absorbance was 
measured on a microplate reader (PerkinElmer, Waltham, MA) at 450 nm, with filters at 
ƛmax 460 nm, and the percent cytotoxicity was calculated as the percentage cell viability 
(relative to the WST-dimethyl sulfoxide reduction) compared to controls. The cell 
viability assays were carried out for a 1:1 dilution series in the concentration range (Figure 
4.1). 
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Figure 4.1 The cell viability was measured using a colorimetric assay on 96-well 
plates with WST reagent and dimethyl sulfoxide (Microbial viability assay kit-
WST). 
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4.3 Results 
 
4.3.1 Effect of LEA peptide expression in E.coli on salt tolerance 
E. coli cells expressing the LEA peptide were exposed to 3%, 5%, and 7% NaCl as 
harsh conditions for survival and growth. No colony of E. coli BL21 (DE3) without the 
expression of LEA peptide was observed on the plates supplemented with 7% NaCl. The 
colony number with 3%, 5%, and 7% NaCl was increased with IPTG compared to the 
control strain without IPTG in a concentration-dependent manner. The survivability ratio 
of transformant under the expression of LEA peptide was higher than those not expressing 
LEA peptide for at all NaCl concentrations tested (Table 4.1) (Figure 4.2). The number 
of colony-forming units was highest at 1.0 mM IPTG (Figure. 4.3 a–c) under NaCl stress 
at all concentrations. Collectively, these results showed that the expressed LEA peptide 
conferred salt tolerance to the host cells, but had little effect on 7% NaCl salt tolerance. 
Therefore, the function and effects of LEA peptide expression on the growth of the 
recombinants under high salt tolerance were studied in more detail. 
 
Table 4.1 Survivability ratio of LEA peptide expressed E. coli BL21 (DE3) on the 
plates supplemented with high concentration of salt (NaCl) 
 
Salt concentration 
Survivability ratio (%) 
Without LEA With LEA 
3 % 50-200 100-500 
5% 10-50 50-70 
7% 0               1-2 
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Figure 4.2 Growth performance of E.coli under salt tolerance after expression of 
LEA peptide. 
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Figure 4.3 Growth performance of E.coli under salt tolerance after expression of 
LEA peptide. The cultures of expressed E. coli BL21 (DE3) under different 
concentration of IPTG were spread on salt contanting LB plates a) 3% salt, b) 5% 
salt and c) 7% salt. The statistical significance of the difference was confirmed by t-
test, **P < 0.01; ***P < 0.001. SE±5. 
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4.3.2 Temperature tolerance of the expressed LEA peptide in E.coli 
The cultures of recombinant E. coli with the pRSF-Duet LEA under different 
concentration of IPTG incubated at 48°C for 30min were spread on LB plates.  The colony 
number was increased with increase with IPTG concentration, the greater colony numbers 
were shown under the 1.0 mM IPTG compared to the control grown without IPTG. On 
the other hand, the cold shocked E.coli was also shown that the colony number was 
increased with increase with IPTG concentration. LEA peptide increased the growth 
capacity of the recombinant under both the heat and cold shock treatment compared to 
the control (Figure. 4.4). 
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Figure 4.4 Express LEA peptide response to heat and cold tolerance in E.coli. The 
cultures of expressed E. coli BL21 (DE3) under different concentration of IPTG 
incubate at a) 48°C for 30min and b) 4°C for 24h were spread on LB plates. The 
statistical significance of the difference was confirmed by t-test, ***P < 0.001. SE±5. 
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4.3.3 Cell viability of recombinant E. coli under salt stress  
The rate of WST reduction in the solution (determined by the colour change) was linear 
(Figure 4.5) over a 4hr period, and the amount of dye reduced at OD500-600 yielded 2 × 
104 cells with a coefficient of variation of replicate wells of 2 to 5%. This experiment 
demonstrated the utility of the WST assay kit for determining cell viability, and the 
optimal condition was determined to be a concentration of 2 × 104 cells/well using the 
WST-dimethyl sulfoxide solution at a final concentration of 0.5 mg/ml with incubation 
of 4 to 8hr (Figure4.5 (a)).  Using IPTG as an inducer of the pRSF-Duet LEA plasmid 
showed that expression of the LEA peptide significantly altered the WST reducing ability 
in recombinant cells. Although cells expressing the LEA peptide showed greater viability 
under both 5% and 7% NaCl at 4hr compared to the control, the viability of the 
recombinant expressing the LEA peptide was reduced at 8hr under salt stress, reaching 
the same level as the control (Fig. 4.5(b)).  
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Figure 4.5 Cell viability of LEA peptide expressed E.coli in high salt concentration 
media. The cultures of E.coli BL 21 (DE 3) cell expressed with or without 0.1mM 
concentration of IPTG transformed in to the 5% and 7% high salt concentration LB 
media and incubated at 4hr and 8hr a) Cell growth curves of expressed and 
unexpressed transfromat at 5% and 7% salt containing LB media. b) Cell viability 
curves of expressed and unexpressed transfromat at 5% and 7% salt containing as 
described under materials and methods. [A] unexpressed LEA peptide 
transformant in 5% salt LB media, [B] expressed LEA peptide transformant in 5% 
salt LB media, [C] unexpressed LEA peptide transformant in 7% salt LB media and 
[D] expressed LEA peptide transformant in 7% salt LB media. SE±5. 
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4.4 Discussion 
The wide variety of molecular and biochemical processes are triggered the downstream 
process of the peptide to cell-cell signalling (Marshall et al., 2011; Uttara et al., 2009). 
The 32 amino acids short peptide improving and enhancing the salt tolerance (Tam et al., 
2002).  LEA proteins have been detected in stress tolerance, freezing tolerance, and 
drought tolerance in response to different stages of plant development (Cuming, 1999; 
Hoekstra et al., 2001; Wang et al., 2003; Wise and Tunnacliffe, 2004). In legumes, as 
expected, their accumulation during late embryogenesis this has been reported for 
common bean, soybean or Medicago truncatula seedlings, M. truncatula, G. max, 
Arachis hypogaea and P. vulgaris(Arenas-Huertero et al., 2009; Battaglia and 
Covarrubias, 2013; Delahaie et al., 2013).  BBC1 protein is highly hydrophilic and rich 
in lysine, arginine, and histidine residue of amino acids. BBC1 gene highly expressed in 
benign and malignant breast tumors(Sáez-Vásquez et al., 1993; Tanaka et al., 2001; Tong 
et al., 2002). BBC1 gene also present in animals species, in plants, and also in 
microorganisms(Andersson, 2003; Kwon et al., 2003; Sáez-Vásquez et al., 1993; Tanaka 
et al., 2001). BBC1 protein has a similar function to LEA proteins to be responsive to 
desiccation and might have some roles in protecting the proteins and membranes under 
stressed conditions, such as desiccation and chilling (Hughes and Dunn, 1996; Miyasaka 
et al., 2000; Tanaka et al., 2004). In plants, several reports indicate that over-expression 
of LEA proteins in tolerance to water scarcity (Goyal et al., 2005b; Xiao et al., 2007; 
Zhang et al., 2000). From various groups confers tolerance to a variety of water deficit 
treatments, especially the expression of (LEA3) PM2 soybean protein conferred salt and 
temperature tolerance in E.coli(Liu and Zheng, 2005). LEA3-like protein has been shown 
that increases cellular viability after desiccation in the brine shrimp Artemia franciscana, 
and hyperosmotic stress in Drosophila melanogaster cells after water deficient 
(Moriyama and Powell, 1996; Sharon et al., 2009; Wise, 2003).  
LEA peptide, based on the sequence of Group 3 LEA protein in the previous chapter I 
already explained and discussed(Ikeno and Haruyama, 2013; Pathak et al., 2017). In this 
section, I studied the functional mechanism of LEA peptides in the E. coli cells. E.coli is 
a typical model system for prokaryotic cells(Baneyx, 1999; Taniguchi et al., 2010). In the 
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present study, the 11-mer amino acids LEA peptide-encoding gene was expressed through 
the pRSF-Duet vector and examined its effects on growth performance under salt, heat, 
and cold stress. Although I cannot yet elucidate the mechanism of peptide expression in 
E. coli. In the previous study Ikeno et al., 2013 reported that this LEA peptide exerts its 
function after translation(Ikeno and Haruyama, 2013). Thus, it is possible that the 
efficiency of conversion plays an important role in efficiently expressing this LEA 
peptide. Indeed, in a previous chapter, expression of a target protein could be enhanced 
through co-expression of this short LEA peptide. A high salt concentration causes 
intracellular imbalance and damage to cellular proteins and membranes (Hasegawa et al., 
2000; Mahajan and Tuteja, 2005; Zhu, 2001). Here, I demonstrated that recombinants 
expressing the short LEA peptide grew and survived better under a high salt concentration 
and temperature stress (heat and cold) compared to E. coli not expressing the peptide. 
Similarly, expression of a soybean PM2 LEA protein based polypeptide resulted in 
enhanced salt tolerance to host cells. The different types of PM2 polypeptides are 
contained 262-282 amino acids residues(Liu and Zheng, 2005; Liu et al., 2010). The 
expressing BBC1 gene in the E.coli cells confers the stress tolerance against the cellular 
dehydration(Miyasaka et al., 2000). 
Goyal et. al., 2005 and S. Chakrabortee et al., 2007 suggested the physiological roles of 
LEA protein in the stabilization of sugar groups for protein stabilization via protein-
protein interactions, sequestration, and formation of structural networks. Such networks 
have been hypothesized to increase the cellular resistance to physical stresses imposed by 
desiccation(Chakrabortee et al., 2007; Goyal et al., 2005b). It is becoming increasingly 
clear that an ensemble of micro- and macromolecules are an essential requirement for 
stabilizing the mobile condition during exposure to abiotic stress(Wise and Tunnacliffe, 
2004; Wolkers et al., 2001). The PvLEA 22-mer polypeptide takes on a random coil 
structure in aqueous solution with sodium chloride and potassium chloride but shows a 
conformational change in a dry state by forming an alpha-helix, which functions to protect 
cells against desiccation-induced anti-aggregation (Furuki et al., 2012; Furuki et al., 2011; 
Hatanaka et al., 2015; Shimizu et al., 2010). LEA4 protein over-expression or deficiency 
led to an enhance or a reduce the number of floral and axillary buds in Arabidopsis plants, 
after desiccation conditions respectively, Moreover, the PvLEA4 protein was shown to 
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act a molecular shield conferring adequate protection against water stress and ultraviolet 
irradiation (Hatanaka et al., 2013; Ryabova et al., 2016). Based on these previous findings 
and the present results, I hypothesize that the expressed short LEA peptide in the 
transformant acts as a molecular shield to increase the survivability under abiotic stress, 
playing a similar role to full LEA proteins and the 22-mer polypeptide. I currently focus 
on the investigating the specific effects and expression mechanism of the LEA peptide in 
the transformant under abiotic stress. 
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Chapter 5: General conclusion 
 
The present functional bioactive peptide scenario highlights their crucial role in living 
organisms. The peptides are the protein molecules, and bioactive peptide has encouraged 
the research community to the development of significant bioactive peptide for the 
potential use of power and circumstances of a bioactive peptide on human health as 
identification of useful biomolecules, therapeutic purposes, diagnosis of genetic diseases, 
as food additives.  In nearly all species, natural expression of bioactive peptides occurs in 
limited quantities. As a consequence, research has focused on the production of bioactive 
peptides and review of their mode of function and bio-properties in applications of 
multiple areas. The main focus in this study was the establishment of a LEA peptide with 
versatile properties for applications in numerous fields using an efficient co-expression 
system to produce recombinant protein, and characterization of its functional properties 
against different abiotic stresses.  
    In the second chapter, it is concluded that the length and charge distribution on the 
LEA peptide sequence was optimized for the efficient co-expression of the target protein. 
The recombinant protein interaction of the LEA peptide offers a unique advantage in 
retaining stable complexes. The characteristic properties of the LEA peptide are the same 
as the G3LEA protein that is a hypothesis in this thesis. Various types of LEA peptide 
were designed based on the original LEA I peptide. These results indicate that there is a 
correlation between expression level of the target protein and amino acid composition in 
LEA peptide sequence, which can be exploited to predict the expression level of genes. 
Previously, designed LEA peptide LEA-I and LEA-II, the role of charged amino acids 
and hydrophobic amino acids enhanced the target protein expression. From this study, it 
is also clear that the role of charged and hydrophobic amino acids is important in the 
design of the LEA peptide sequence. The mutated LEA peptide (13aa) enhanced target 
protein expression through the co-expression system. The expression of the target protein 
was drastically decreased by the N-terminal deletion of the second D from the mutated 
LEA peptide. The length of the constructed long peptide LEA K 23aa and LEA K 24aa 
decreased the expression of the target protein, which supports previous data. The effective 
role of C-terminal amino acids in the long peptide was observed after replacing the LEA 
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K 23aa (K) Lysine with other amino acids. In the other changed, amino acid at C-terminus 
LEA K 23aa expression of target protein got enhanced. In the short peptide, the 
fluorescence intensity of GFP expression effectively decreases with a decrease in the 
length of the LEA peptide; LEA K 9aa and LEA K 5aa show less expression of GFP in 
comparison with an expression without LEA peptide. 
  Similarity, to LEA proteins of known function and their high structural flexibility has 
hampered the progress regarding their activity and the implicated mechanisms. The 
results of this study suggest that that this approach will improve the performance of target 
protein co-expression by existing methods used previously. However, the role of amino 
acids in the LEA peptide sequence is still unknown. The gene of LEA peptide sequence 
based on codon usage but the increased or decreased expression of the target protein is 
based on LEA peptide sequence composition, length, nature and size, it’s under 
discussion. But, the LEA peptide C-terminus amino acid and the charged amino acid are 
very important to co-express the target protein. In the future, other amino acids may be 
explored for their value in the design of new LEA peptide sequences. 
  The third chapter concluded that the dual expression system and the time-dependent 
system are highly versatile to produce the recombinant protein. In the previous study, 
enhances the target protein through the LEA peptide co-expression system. The target 
protein and LEA peptide expression induced by the IPTG, it’s difficult to control each 
gene expression level at the same time. Dual expression system based on the induction 
concertation of IPTG and arabinose. The pRSF Duet plasmid encodes the gene for LEA 
peptide and pBAD/Myc-His plasmid encodes the gene for GFP expression. In the 
previous study, the role of LEA peptide expression it enhanced the target protein or not, 
it’s not clear to say; but in this study the LEA peptide enhances the expression of GFP. 
The dual expression system significantly increased the target protein expression when the 
LEA peptide was expressed before target protein expression. Through this system the 
expression of the target protein can be controlled, and at the same time, two or more than 
two recombinant proteins can be induced. These results will contribute to hypothesis 
verification for LEA peptide functional mechanisms. 
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  The fourth chapter concludes that the relevant advances concerning their advancement 
at transcript level and protect and stabilize the protein molecule inside the cell. The 
available information suggests that LEA proteins and the 22 amino acid LEA peptide are 
expressed as a tolerance response to water deficit conditions, and this notion has gained 
experimental support. Moreover, as proteins whose flexible structure turns them a good 
model to analyze the functional relevance of this structural flexibility in the response of 
plant and insect cells to stress. Because most of the information regarding LEA proteins 
have been obtained, and LEA peptide is based on the LEA protein this hypothesis is 
similar regarding the constructed LEA peptide. This LEA peptides increased the 
survivability of transformant in the high concentration 5% and 7% salt stress and 
temperature tolerance. 
   This work demonstrated that the nature, position and structure of amino acids in the 
LEA peptide play a very important role in the enhancement of target protein expression 
through a co-expression system. Through the dual expression system using arabinose and 
IPTG induction, the production rate of target protein expression was controlled. LEA 
peptide has contributed to building hypotheses regarding their role in E. coli abiotic stress 
tolerance to conditions of salinity or extreme temperatures. To important advances 
concerning their advancement at transcript level and protect and stabilize the protein 
molecule inside the cell. LEA peptide accumulation and expression patterns vary in 
response to abiotic stress, throughout development, their role in various processes, and 
their structural properties. Because most of the data regarding LEA proteins have been 
published, and LEA peptide is based on the LEA protein, the hypothesis is similar 
regarding the constructed LEA peptide. The notion of LEA proteins and the 22 mer motif 
of the LEA peptide being involved in tolerance to desiccation conditions has gained 
experimental support, and as proteins whose flexible structure turns them as an excellent 
model to study the functional relevance of protein structural flexibility in the response of 
plant and insect cells to stress. In this work, the data showed that the nature, position, and 
structure of amino acid in the LEA peptide plays a significant role in enhancing target 
protein expression through the co-expression system. According to my hypothesis, and 
based on the LEA protein function, I conclude that the LEA peptide acts as a molecular 
shield to enhance and provide resistance of the target protein. Under abiotic stress 
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conditions, this LEA peptide enhances E. coli survival through its action as a molecular 
shield. In my future research, I will study and discuss the functional mechanisms and 
biological properties of LEA peptide in cells   
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Appendix 
 
[i]Culture medium and plate 
LB (Luria-Bertani) liquid medium 
Reagent Amount to add 
H2O 950 mL 
Tryptone 10 g 
NaCl 10 g 
Yeast extract 5 g 
 
LB (Luria-Bertani) agar plate 
Reagent Amount to add 
H2O 950 mL 
Tryptone 10 g 
NaCl 10 g 
Yeast extract 5 g 
Agar 15g 
 
LB medium: 
Dissolve 10 g tryptone, 5 g yeast extract, and 10 g NaCl in 950 mL deionized 
water.  Dissolve 10 g tryptone, 5 g yeast extract, and 10 g NaCl in 950 mL deionized 
water. Adjust the pH of the medium to 7.0 using 1N NaOH and bring volume up to 1 liter. 
Autoclave on liquid cycle 121°C for 20 min at 15 psi. Allow solution to cool to 55°C, and 
add antibiotic if needed (50µg / mLKam). Store at room temperature or +4°C. 
 
LB agar-plates: 
Prepare LB medium as above, and add 15 g/L agar before autoclaving. 
After autoclaving, cool to approx. 55°C, add antibiotic and pour into petri dishes. 
Let solidified the LB media, then invert and store at +4°C in the dark. 
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[ii] Phosphate Buffer (0.1M) 
The buffer solution was prepared by dissolving 1.76 g of NaH2PO4.2H2O and 5.49 g of 
Na2HPO4 in 500 ml of water. The pH was adjusted to 7.0 using HCl and NaOH. 
 
[iii] 1xTE buffer (pH 8.0) 
The 1x TE buffer solution was prepared by mixxing 10ml of 1M Tris-HCl pH 8.0  and 
2ml 0.5M EDTA pH 8.0 in 980 ml of water. The pH was adjusted to 8.0 using HCl and 
NaOH. 
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